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1 Summary 
Polycomb group (PcG) proteins are chromatin modifiers involved in heritable gene 
repression. Two main PcG complexes have been characterized: Polycomb repressive 
complex (PRC) 2 is involved in the initiation of gene silencing, whereas PRC1 
participates in the stable maintenance of gene repression.  
Pcgf4 (Polycomb group protein, Bmi1) is one of the most studied PRC1 members with 
essential functions for embryonic development and adult stem cell self renewal. In 
embryonic stem cells (ES cells), Pcgf4 is poorly expressed while its paralogs (Pcgf1, 
Pcgf2, Pcgf3, Pcgf5 and Pcgf6) are expressed at higher levels. The relevance of the Pcgf 
paralog Pcgf6 for the maintenance of ESC pluripotency has not been addressed so far.  
My analyses revealed that Pcgf6 was the most expressed Pcgf paralog in undifferentiated 
ES cells. When ES cells differentiated, gene expression of Pcgf6 strongly declined. To 
investigate the functions of Pcgf6 in ES cells, we established a doxycycline (dox) 
inducible shRNA-targeted knockdown system according to publications by Seibler et al. 
(Seibler et al. 2005; Seibler et al. 2007). Following dox-induced knockdown (KD) of 
Pcgf6, we observed decreased ES cell colony formation. In parallel, gene expression of 
pluripotency markers Oct4, Nanog and Sox2 was reduced upon dox-treatment, wheras 
the expression of mesoderm genes such as T (Brachyury) were up-regulated. Further, 
microarray analysis revealed de-repression of several spermatogenesis-specic genes 
upon Pcgf6-KD, suggesting that Pcgf6 may play a role during spermatogenesis. Upon in 
vitro differentiation, Pcgf6-KD ES cells showed increased hemangioblast formation, 
paralleled by increased hematopoietic development.  
In summary, results of this study suggest that Pcgf6 is involved in maintaining ES cell 
identity by repressing lineage-specific gene expression in undifferentiated ES cells.  
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2 Zusammenfassung  
Polycomb Gruppe (PcG) Proteine sind Chromatin-Modifikatoren, die an der vererbbaren 
Genrepression beteiligt sind. Primär wurden bisher zwei PcG-Komplexe charakterisiert: 
Polycomb-repressiv-Komplex (PRC) 2, der die ersten Schritte des Gen-Silencings 
übernimmt, und PRC1, der an der stabilen Aufrechterhaltung der Genrepression 
beteiligt ist.  
Pcgf4 (Bmi1) ist das am besten untersuchte PRC1-Mitglied. Pcgf4 hat wichtige 
Funktionen in der embryonalen Entwicklung und in der Selbst-Erneuerung adulter 
Stammzellen. In embryonalen Stammzellen (ES-Zellen) wird Pcgf4 kaum exprimiert, 
während seine Paraloge (Pcgf1, Pcgf2, Pcgf3, Pcgf5 und Pcgf6) höher exprimiert sind. 
Die Bedeutung des Pcgf-Paralogs Pcgf6 für die Aufrechterhaltung der Pluripotenz von 
ES-Zellen wurde bislang nicht untersucht. 
Meine Analysen zeigten, dass Pcgf6 der am meisten exprimierter Pcgf-Paralog in 
undifferenzierten ES-Zellen war. Während der Differenzierung von ES-Zellen wurde die 
Expression von Pcgf6 stark reduziert. Um die Funktionen von Pcgf6 in ES-Zellen zu 
untersuchen, habe ich ein Doxycyclin (dox)-induzierbares shRNA-Expressionssystem für 
den gezielten Knockdown (KD) von Pcgf6 nach Seibler et al. (Seibler et al. 2005; Seibler 
et al. 2007) etabliert. Nach dox-induziertem KD von Pcgf6 beobachtete ich eine 
Verringerung der ES-Zell-Kolonie-Bildung. Die Expression der Pluripotenzmarker Oct4, 
Nanog und Sox2 war nach Dox-Behandlung reduziert, während die Expression 
mesodermaler Gene, wie z.B. T (Brachyury), hochreguliert wurden. Außerdem zeigten 
Microarray-Analysen eine De-Repression Spermatogenese-spezifischer Gene nach KD 
von Pcgf6, was darauf hindeutete, dass Pcgf6 eine Rolle in der Spermatogenese spielen 
könnte. In der in-vitro- Differenzierung  zeigten Pcgf6-KD-ES-Zellen, neben einer 
erhöhten Bildung von Hämangioblasten, mehr hämatopoetische Vorläufer.  
Zusammenfassend zeigten die Daten dieser Studie, dass das Pcgf-Paralog Pcgf6 an der 
Aufrechterhaltung der ES-Zell-Identität durch Unterdrücken lineage-spezifischer 
Geneexpression in undifferenzierten ES-Zellen beteiligt ist. 
 
 
 
 
7 
 
 
3 Abbreviations 
7AAD  7 amino actinomycin D 
%  percent 
(v/v)  volume by volume 
°C  degree Celsius 
ac acetylation 
AP  alkaline phosphatase 
BM  bone marrow 
bp  base pair 
BSA  bovine serum albumine 
ChIP  chromatin immunoprecipitation 
C-terminus / C-terminal  carboxy terminus 
d  day(s) 
DAPI  4',6-diamidino-2-phenylindole 
ddH2O  double distilled water 
DMEM  Dulbecco s´ Modified Eagles Medium 
DMSO  dimethyl sulfoxide 
DNA  Deoxyribonucleic acid 
DNase  Deoxyribonuclease 
Dnmt  DNA methyltransferase 
dNTP  desoxy ribonucleotide triphosphate 
DTT  dithiotreitol 
E. coli  Escherichia coli 
e.g.  exempli gratia, for example 
EB embryoid body 
EDTA  Ethylendiamintetraacetat 
eGFP  enhanced green fluorescent protein 
ES embryonic stem 
ESC embryonic stem cell 
et al.  et alii (and others) 
EtOH  Ethanol 
FACS  fuorescence activated cell sorting 
FBS Fetal Bovine Serum 
FCS  fetal calf serum 
FGF  fibroblast growth factor 
g  gram 
h  hour 
H  histone 
HD  hanging drop 
HDAC histone deacetylase 
HMT  histone methyltransferase 
HPC  hematopoietic progenitor cell 
HPSC  hematopoietic progenitor and stem cell 
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HRP  horseradish peroxidase 
HSC  hematopoietic stem cell 
ICM  inner cell mass (of blastocyst) 
IL  interleukine 
IMDM  Iscove's modied Dulbecco's medium 
k kilo 
K  lysine 
kb  kilo bases 
KDM  histone lysine demethylase 
KO  knockout 
l  liter 
LB  Luria-Bertani 
LIF  leukemia inhibitory factor 
Lin  lineage 
m  milli, 10-3 
M  Molarity [mol/l] 
MC  methylcellulose 
me  methylation 
MEF  mouse embryonic fibroblast 
min  minute 
mRNA  messenger RNA 
N-terminus / N-terminal Amino Terminus 
OD Optical density  
p  pico,  
PBS  Phosphate Buffer Saline 
PCR  Polymerase Chain Reaction 
Poly-A 
Pcgf 
poly adenylation 
Polycomb group ringfinger protein 
PRC1  Polycomb repressive complex 1 
PRC2  Polycomb repressive complex 2 
RNA  Ribonucleic Acid 
rpm  revolutions per minute 
s  second 
SDS  Sodium Dodecyl Sulfate 
TAE  Tris Acetate EDTA 
TBE  Tris Borate EDTA 
TC  tissue culture 
TE  Tris EDTA 
TEMED  N,N,N',N'-Tetramethylethylenediamine 
Tris  Tris-(Hydroxymethyl)-Aminoethan 
trxG  Trithorax group 
U  units 
UV  ultra violet 
μ  mikro  
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4 Introduction 
4.1 Stem cells 
Stem cells, due to their ability to self-renew and their developmental potential, are 
invaluable tools for basic research such as developmental biology, drug discovery and 
disease modelling. In addition, the broad and unique differentiation potential makes 
them promising building blocks for future regenerative strategies. 
 
4.1.1 The stem cell system in vivo 
In multicellular organisms, cells are organized in hierarchic systems with stem cells at 
the top of the hierarchy followed by transient amplifying progenitor and down to 
differentiated effector cells (Potten and Loeffler 1990). A stem cell is able to self-renew, 
i.e. generating a complete phenocopy that shares the same characteristics with the 
mother stem cell (Orford and Scadden 2008). During development stem cells with 
distinct properties arise.  According to their developmental potential, stem cells are 
classified as toti-, pluri- or multipotent. In mammals, live starts with a single totipotent 
cell, the fertilized egg (zygote). A totipotent cell is capable to develop into a complete 
organism, including extra-embryonic tissues. Totipotency, however, is lost during 
progression of embryonic development. At pre-implantation, during the blastocyst 
stage, cells in the inner cell mass (ICM) are pluripotent. These pluripotent cells can 
produce all cell types of the 3 germ layers: endoderm, mesoderm and ectoderm, but fail 
to generate extra-embryonic tissues. In both embryonic and adult tissues, further 
specialized stem cells, known as somatic or adult stem cells, fulfill cell generation and 
regeneration following injury to guarantee tissue homeostasis. Adult stem cells are 
lineage-restricted stem cells that are capable to differentiate into effector cells of a 
particular stem cell system (Mitsiadis et al. 2007; Voog and Jones 2010). For example, 
hematopoietic stem cells (HSCs) give rise to all cell types of the blood (Seita and 
Weissman 2010).  
Within the blastocyst ICM, pluripotent cells exist only transiently. As development 
proceeds, the ICM cells generate differentiated progeny and finally generate the embryo 
proper. However, pluripotent ICM cells can be isolated and adapted to in vitro culture, 
under which they remain undifferentiated and propagate as pluripotent embryonic stem 
cells (ES cells)(Evans and Kaufman 1981; Martin 1981). 
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4.1.2 Embryonic stem cells  
ES cells are pluripotent in vitro derivates of cells of the ICM of preimplantation 
blastocyst-stage embryos. In the presence of leukemia inhibitory factor (LIF) and mouse 
embryonic fibroblasts (MEFs), ES cells remain undifferentiated and self-renewing. In 
contrast, external differentiation signals, such as withdrawal of LIF, induce ES cells to 
differentiate into all kinds of somatic cell types including germ cells and many clinically 
relevant cell types (e.g. hematopoietic, neural)(Evans and Kaufman 1981; Martin 1981; 
Brook and Gardner 1997; Nichols et al. 1998). Upon ectopic transplantation, ES cells 
form teratomas that are constituted of cell types of the 3 germ layers.  
Under standard ES cell culture conditions, ES cells typically grow in compact and sharp-
edged colonies in the presence of serum, LIF and on MEFs. LIF activates the 
transcription factor STAT3 by binding to a heterodimeric receptor complex consisting of 
gp130 and LIF receptor (Davis et al. 1993; Niwa et al. 1998; Matsuda et al. 1999).  
Expression of transcription factors such as Nanog, Sox2 and Klf4 is induced by STAT3, 
thus LIF-signaling promotes the undifferentiated state of ES cells (Cartwright et al. 2005; 
Suzuki et al. 2006; Hall et al. 2009). Upon LIF and feeder cell withdrawal, ES cells 
spontaneously differentiate and form complex-structured cell aggregates, so called 
embryoid bodies (EBs) (Martin and Evans 1975). Multiple types of tissue-specific 
progenitor cells arise during EB formation and differentiation. For enrichment of a 
specific cell population, differentiation conditions can be adjusted by using selected 
culture medium compositions and by addition of cell lineage-specific growth factors 
such as mesoderm/hematopoiesis-promoting cytokines. Thus, ES cells provide the basis 
for establishing an in vitro model of early mammalian development. In addition, because 
ES cells allow the induction of genetic modifications with relative ease, they offer a 
widely used platform to study specific gene functions involved in pluripotency and 
during ES cell differentiation. Furthermore, ES cells represent a potential source of 
differentiated cell types for cell replacement approaches. Clinical trials based on human 
ES cells (hES cells) have already been published in 2011(Goldring et al. 2011). In early 
2012, Schwartz et al. reported the safe engraftment of hESC-derived retinal pigment 
epithelium cells into patients suffering from macular degeneration. Signs of 
hyperproliferation, tumorigenicity, ectopic tissue formation or graft rejection were not 
observed (Schwartz et al. 2012). More progresss in this area can be expected in the near 
future. 
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A fascinating and still poorly understood property is that following injection of mouse ES 
cells into blastocysts, ES cells integrate into the ICM and generate chimeric embryos 
including the germ line (Bradley et al. 1984). Thus, using genetic manipulation of in vitro 
cultured ES cells the functional characterization of genes of interest during development 
of a mouse is feasible.  
 
4.1.3 The core pluripotency network 
The initiation and the maintenance of the pluripotent state of ES cells require a highly 
regulated molecular network of pluripotency factors. Among these factors, a limited 
number of transcription factors (TFs) are of significant importance. As shown by 
Takahashi and Yamanaka in 2006, the reprogramming of mouse adult fibroblasts to 
induced pluripotent stem cells (iPS) could be induced by overexpression of just 4 TFs: 
Oct4, Sox2, c-Myc and Klf4 (Takahashi and Yamanaka 2006). This showed that the 
initiation of pluripotency can be achieved by a small set of TFs.  Other factors and 
mechanism important for pluripotency are chromatin modifiers, factors of the cellular 
memory system such as polycomb group repressive complexes 1 and 2 (PRC1, PRC2) 
and extracellular signaling molecules such as LIF (Medvedev et al. 2012).  
The pluripotency-associated TFs Oct4, Sox2 and Nanog are highly expressed in the ICM 
cells, epiblast and in ES cells (Rosner et al. 1990; Pesce and Scholer 2000; Avilion et al. 
2003). These transcription factors establish and control the core pluripotency network 
(Chambers and Smith 2004; Niwa 2007; Silva et al. 2008). But it is not just the presence 
or absence of these TF important, also the precise expression levels of the POU-family 
member Oct4 (Pou5f1), plays central roles in blocking differentiation and allowing self-
renewal. Repression or overexpression of Oct4 leads to a loss of ES cell characteristics 
and induces differentiation towards the trophectodermal or meso- and endodermal 
lineages, respectively (Nichols et al. 1998; Niwa et al. 2000). Oct4 complexes with 
various TFs including Sox2 and Nanog and modulators of Oct4 function (Pardo et al. 
2010). Together with Sox2, Oct4 forms heterodimeric complexes within the promoter 
regions of genes that regulate pluripotency and embryonic development (Remenyi et al. 
2003; Wang et al. 2007). Similar to targeted deletion of Oct4, deletion of Sox2 in ES cells 
results in trophectodermal differentiation combined with a loss of pluripotency (Avilion 
et al. 2003; Niwa et al. 2005; Masui et al. 2007; Niwa 2007). In contrast to Oct 4 and 
Sox2, Nanog is not required for the establishment of ES cell pluripotency but stabilizes 
the undifferentiated state by maintaining the self-renewal capacity of ES cells (Chambers 
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et al. 2003; Mitsui et al. 2003; Chambers et al. 2007; Torres and Watt 2008). Oct4 and 
Sox2 positively regulate their own expression, and also the expression of Nanog (Boyer 
et al. 2005; Loh et al. 2006). Oct4, Sox2 and Nanog co-occupy a large set of target 
promoters. The 3 TFs activate genes associated with pluripotency and self-renewal and 
repress the expression of genes involved in differentiation and lineage commitment at 
the same time (Boyer et al. 2005; Chew et al. 2005; Okumura-Nakanishi et al. 2005; 
Rodda et al. 2005; Loh et al. 2006; Wang et al. 2006; Masui et al. 2007; Young 2011). 
Among the factors that are regulated by the core pluripotency network, polycomb group 
(PcG) proteins play a central role for the repression of developmental regulators in ES 
cells ((Boyer et al. 2006; Leeb and Wutz 2007; Cole and Young 2008; Endoh et al. 2008; 
Kashyap et al. 2009). For instance, double knockout of PcG proteins Ring1A/B 
(Ring1A/B-dKO) led to de-repression of differentiation associated genes in ES cells and 
blocked ES cell self-renewal(Endoh et al. 2008). Further analyses revealed a significant 
overlap of de-repressed genes in Ring1A/B-dKO ES cells and Oct4-KO ES cells. In 
addition, ChIP and ChIP-on-Chip analyses showed that PRCs require Oct4 to engage their 
target gene promoters in ES cells and vice versa (Endoh et al. 2008). Together, these 
data suggested a functional cooperation between PcG proteins and the core pluripotency 
TFs, and thereby, demonstrated an essential role for PRCs in maintaining ES cell identity.      
 
4.1.4 Chromatin structure in ES cells 
The capability of ES cells to differentiate into derivatives of the 3 germ layers requires a 
molecular flexibility of ES cell-specific gene expression programs. Indeed, a high 
flexibility of gene expression is characteristic for pluripotent ES cells, e.g. gene 
expression programs are not permanently silenced but stay accessible for immediate 
transcription. An unrestricted chromatin architecture is fundamental for ES cells. 
Electron microscopy of ES cell nuclei revealed that their chromatin is homogeneous, 
decondensed and rich in euchromatin. In contrast, differentiated nuclei exhibit frequent, 
distinct heterochromatin domains (Efroni et al. 2008; Golob et al. 2008). For example, 
while heterochromatin domains in ES cells are rather diffuse, upon differentiation they 
become more defined with clear boundaries (Meshorer et al. 2006; Jorgensen et al. 
2007). Euchromatin is generally associated with transcriptionally active genes, and 
indeed, global transcription levels are elevated in ES cells as compared to differentiated 
cells (Efroni et al. 2008; Golob et al. 2008). The dynamics, i.e. the molecular exchange 
rates, of chromatin proteins is higher in undifferentiated ES cells than in differentiated 
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progeny (Meshorer et al. 2006; Jorgensen et al. 2007). By fluorescence recovery after 
photo-bleaching (FRAP) analyses of GFP-tagged histone proteins such as 
heterochromatin protein 1 (HP1), histone H1 or core histones, fast and highly mobile 
chromatin fractions were observed in pluripotent cells (Meshorer et al. 2006).  
In addition, global levels of histone modifications that are commonly associated with 
gene expression are higher in ES cells than in differentiated cells. Histone modifications 
such as H3K9ac, H3K14ac, H3K4me3 and H3K36me3 were reported to be prevalent in 
undifferentiated ES cells (Lee et al. 2004; Meshorer et al. 2006; Bartova et al. 2008; 
Efroni et al. 2008; Bian et al. 2009; Krejci et al. 2009). Activating chromatin 
modifications increase the accessibility of the chromatin to RNA polymerase, where 
repressing modifications decrease the accessibility to RNA polymerase. In contrast, 
levels of repressive histone modifications, like H3K9 methylation, become globally 
elevated upon differentiation (Aoto et al. 2006; Meshorer et al. 2006; Efroni et al. 2008; 
Krejci et al. 2009; Wen et al. 2009).  
Another regulatory principle that is acting in pluriptent cells is bivalent chromatin. 
Bivalent chromatin describes histones that carry both activating and repressing  
modifications at the same time (Bernstein et al. 2006). Usually, both do not occur at the 
same location, as they are involved in countering effects; however in bivalent chromatin, 
they are both present. Bivalent chromatin domains are characterized by the 
simultaneous presence of repressive H3K27me3 and activating H3K4me3 marks at 
regulatory sites of genes which are involved in lineage commitment, differentiation and 
tissue development (Surface et al. 2010). As the repressive H3K27me3 modification 
appears dominant over H3K4me3, bivalent genes are expressed only at low levels in ES 
cells. However, upon differentiation respective genes can either be immediately 
activated by removing the H3K27me3 modification via specific histone lysine 
demethylases (KDMs) or expression can stably be repressed by demethylation of H3K4. 
This mechanism, which leads to a flexible epigenetic control of gene expression 
programs upon external or internal stimuli, is not only a feature of pluripotent but also 
of multipotent hematopoietic progenitor and stem cells (HPSCs)(Cui et al. 2009; Adli et 
al. 2010; Weishaupt et al. 2010). Thus, bivalent histone modifications have been 
postulated to be essential for ES cell differentiation into multiple lineages. This view, 
however, was challenged by a recent study in which two principal states of ES cells, due 
to different culture conditions, were compared (Marks et al. 2012). In contrast to the 
standard culture conditions in LIF and serum, the combination of LIF and an inhibitor 
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cocktail (2i) kept ES cells (2i-ES cells) homogenously in a ground state of pluripotency 
without lineage priming (Ying et al. 2008; Guo et al. 2010). The authors reported 
reduced levels of bivalent chromatin modifications and reduced H3K27me3 deposition 
at repressed promoters in 2i-ES cells, but not in serum-cultured ES cells. This 
observation indicated that bivalent domains are less essential for the pluripotent state.  
 
4.2 Polycomb factors 
The development of multicellular organisms requires the coordinated and selective 
expression of lineage-specific genes, and the inheritance of active and repressed 
transcriptional states to daughter cells. As a key component of the cellular memory 
system, Polycomb factors are involved in gene repression and plays crucial roles for ES 
cell pluripotency.  
 
4.2.1 Polycomb group repressive complexes  
PcG proteins are evolutionary conserved regulatory factors that were originally 
identified in Drosophila melanogaster (Lewis 1978; Duncan 1982; Jürgens 1985). These 
proteins were found to be essential for the regulation of homeotic (Hox) genes (Lewis 
1978; Duncan 1982; Jürgens 1985). Mutations of PcG proteins lead to a lack of Hox gene 
repression and cause homeotic transformation (Sparmann and van Lohuizen 2006). In 
mammals, PcG proteins are crucial for many molecular mechanisms involved in stem 
cell identity and differentiation, as well as in cancer (Pietersen and van Lohuizen 2008; 
Bracken and Helin 2009; Schuettengruber and Cavalli 2009). As demonstrated in a 
number of studies in flies and mammals, PcG proteins form multimeric chromatin-
binding complexes which can generally be classified in 2 major groups: PRC1 and PRC2. 
The mammalian PRC2 contains Ezh1/2 (enhancer of zeste), Eed (embyonic ectoderm 
development), Suz12 (suppressor of zeste) and the histone binding proteins 
RbAp46/RbAp48 (Cao et al. 2002; Kuzmichev et al. 2002). The homologs EZH1 and EZH2 
represent the executing H3K27 histone methyltransferase (HMT) enzymes. These 2 
proteins can partially substitute for each other (Shen et al. 2008). EED exists in 4 
different isoforms that are the result of different translational start sites of the EED 
mRNA (Montgomery et al. 2007). Besides the core subunits of PRC2 further proteins 
assemble into the multifactorial PRC2 complex, e.g. Dnmt, Suv39h1, HDACs and Jarid2 
(van der Vlag and Otte 1999; Kuzmichev et al. 2002; Sewalt et al. 2002; Vire et al. 2006; 
de la Cruz et al. 2007; Herz and Shilatifard 2010).  
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In comparison to PRC2, the composition of PRC1 is more complex and heterogeneous. 
The canonical mammalian PRC1 is composed of homologs of 4 Drosophila proteins: 
Polycomb (Pc), Polyhomeotic (Ph), Posterior sex combs (Psc) and Sex combs extra (Sce). 
In addition, a non-canonical PRC1 containing L3mbtl2, Ring1b, Rybp, Pcgf6 and other 
factors was reported for ES cells (Tab. 1).  
In the canonical model of PRC function, PRC2 and PRC1 act in a hierarchical order. 
Firstly, PRC2 catalyzes the tri-methylation of histone H3 at lysine residue 27 
(H3K27me3) which can be recognized and bound by the chromodomain of the PRC1 
component Cbx. Following binding to the chromatin, the Ring1 subunit that possesses 
E3 ubiquitin ligase activity catalyzes ubiquitination of histone H2 at lysine residue 119 
(H2AK119ub) (Cao et al. 2005). H2AK119ub is thought to contribute to transcriptional 
repression by restraining RNA polymerase II from elongation (Stock et al. 2007). 
However, several recent studies reported the PRC2-independent recruitment of PRC1 to 
chromatin and PRC1-associated repression of some loci in absence of H3K27me3 by a so 
far unknown mechanism (Sauvageau and Sauvageau 2010; Surface et al. 2010; Gao et al. 
2012; Tavares et al. 2012).  
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Tab. 1 PRC1 and PRC2 components in Drophophila and mouse/human 
 
 
4.2.2 Heterogeneity of mammalian PRC1 
Multiple mammalian homologs of each Drosophila PRC1 subunit exist in the mammalian 
genome (Morey and Helin 2010; Gao et al. 2012). The PRC1 core-subunits have different 
paralogs (Tab. 1). For example, there are 2 paralogs of Ring1 in the genome (Ring1A and 
Ring1B), 5 paralogs of Chromobox homologs (Cbx2, Cbx4, Cbx6, Cbx7 and Cbx8), 3 
paralogs of Polyhomeotic homologs (Phc1-3) and 6 paralogs of Polycomb group ring 
finger proteins (Pcgf1-6) (see Tab. 1). Different combinations of these paralogs result in 
a considerable heterogeneity of PRC1 with potentially divergent functions (Orlando and 
Paro 1995; Kerppola 2009; Schuettengruber and Cavalli 2009; Surface et al. 2010; 
Vandamme et al. 2011; Gao et al. 2012). Indeed, recent studies reported that whereas 
the Ring1 protein is common to all PRC1 complexes, Pcgf, Cbx and Rybp/Yaf2 
composition functionally define distinct PRC1 complexes that not only occupy different 
genomic loci, but also show distinct cell lineage expression patterns (Trojer et al. 2011; 
Gao et al. 2012; Morey et al. 2012; O'Loghlen et al. 2012; Tavares et al. 2012). Up to date, 
6 groups of PRC1 complexes, PRC1.1 – PRC1.6, were identified that can be distinguished 
by the presence of a different member of the Pcgf family (Gao et al. 2012). In addition, 2 
further PRC1 subtypes were defined by the mutually exclusive presence of Cbx or Rypb 
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(Gao et al. 2012; Tavares et al. 2012). The growing complexity of PRC1 also broadened 
the canonical view of the PRC targeting mechanisms. For example, Pcgf2 (a part of 
PRC1.2) and Pcgf4 (a part of PRC1.4) co-localize with Cbx2 within H3K27me3-enriched 
genomic regions, however, in promoter regions not bound by Cbx2 but bound by PRC1.2 
and PRC1.4 no significant H3K27me3 level was detected (Gao et al. 2012). This 
observation suggested that the classical view of PRC1 recruitment by H3K27me3 
recognition is only applicable to a subset of PRC1 complexes and mostly restricted to 
Cbx-containing PRC1.2 and PRC1.4 (Gao et al. 2012). Thus, targeting mechanisms of 
PRC1.1, 1.3, 1.5 and 1.6 and PRC1.2 and 1.4 without Cbx are probably H3K27me3-
independent. Alternative targeting pathways have been presumed, but still remain 
largely unknown.   
Adding a further layer to the complexity of PRC1-dependent regulation, recent studies 
demonstrated that the expression and functions of some RPC1 members are dependent 
on developmental stages. For instance, while Cbx7 is essential for the maintenance of 
pluripotency and its expression is restricted to pluripotent cells, Cbx2 and Cbx4 are 
associated with lineage commitment and expressed in differentiated cells (Morey et al. 
2012; O'Loghlen et al. 2012). A similar phenomenon was observed in expression of Pcgf 
paralog Pcgf4. While the expression of Pcgf4 is hardly detectable in undifferentiated ES 
cells, it is expressed in differentiated cell types (Ding et al. 2012).  
 
4.2.3 PRC1 in ES cells 
Polycomb complexes play crucial roles both in undifferentiated and differentiating ES 
cells by contributing to the repression of pluripotency and lineage-commitment genes 
(Luis et al. 2012). While knockout of any core subunit of PRC2 was shown to prevent 
proper differentiation of ES cells and embryo development (Luis et al. 2012), 
investigations into the functions of PRC1 subunits in ES cells have been more complex 
due to the heterogeneity of PRC1 family complexes. Analyses of PRC1 subunits function 
in ES cells has revealed a complex picture as recently published data indicate that 
different PRC1 may exist with, at least in part, non-overlapping target genes (Vandamme 
et al. 2011; Gao et al. 2012; Qin et al. 2012). This argues for substantive heterogeneity 
between different PRC1 complexes. Studies of a concomitant knockout of Ring 1A and 
Ring 1B demonstrated an essential role of PRC1 for the maintenance of undifferentiated 
ES cells (Endoh et al. 2008). Ring 1A/B double knockout abrogates PRC1 function. As a 
consequence, ES cell self-renewal was blocked and differentiation-associated genes 
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were de-repressed, along with phenotypic changes indicative of differentiation. Ring 
1A/B double knockout ES cells further caused reduced DNA binding of PRC2 core factor 
EED along with decreased H3K27me3 levels at specific promoters by a yet unidentified 
mechanism, suggesting an interdependence of PRC2 and PRC1 functions in ES cells 
(Endoh et al. 2008). 
In line with the heterogeneity of PRC1, at least two classes of PRC1 were recently 
reported for ES cells: the canonical PRC1.2 containing Cbx7 or Rybp, and the non-
canonical PRC1.6 containing additional components that were previously not detected 
in 293T-Rex cells. PRC1.2 subtypes are composed of either Rybp, Ring1a/b Pcgf2 or 
Cbx7, Ring1A/B  and Pcgf2 (Tavares et al. 2012), whereas PRC1.6 contains L3mbtl2, 
Ring1b, Rybp, Pcgf6, some components of the E2F6 and NuRD repressor complexes, as 
well as the H3K9 dimethyltransferases G9a and GLP (Qin et al. 2012). Insights into the 
recruiting mechanism and function of Rybp- and Cbx-containing PRC1 in ES cells were 
provided by several recent studies. While Rybp-containing PRC1 is recruited to 
chromatin independently of PRC2 and H3K27me3 (Morey et al. 2012; Tavares et al. 
2012), Cbx-containing PRC1 requires the presence of H3K27me3 for its genomic 
localization and therefore follows the canonical model of dependency of PRC1 on PRC2 
(Morey et al. 2012; Tavares et al. 2012). The genomic localization of both PRC1 subtypes 
overlaps in certain genes, it can also be mutually exclusive (Morey et al. 2013). Together, 
the diversity of PRC1 subtypes in ES cells suggests individual and partially redundant 
patterns of regulation that contribute to common and non-overlapping aspects of ES cell 
pluripotency and differentiation. The functional redundancy of PRC1 subtypes would 
also explain why PRC2 function is dispensable while PRC1 function is crucial for ES cells. 
Less understood is the non-canonical mechanism of recruiting Rybp-containing PRC1 to 
chromatin which seems not to be mediated through Rybp (Hisada et al. 2012), but may 
depend on other PRC1 subunits, e.g. Pcgf paralogs (Gao et al. 2012), transcription 
factors, e.g. Runx1 (Yu et al. 2012) or other factors. Notably, genome-wide comparison of 
target genes of canonical PRC1/PRC2 and non-canonical L3mbtl2-containing PRC1 in ES 
cells revealed a low level of overlap (Qin et al. 2012). This observation emphasizes the 
complex and versatile regulatory functions of polycomb complexes in ES cells and 
during early embryonic development.  
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4.2.4 Paralogs of polycomb group ring finger proteins  
Pcgf proteins are mammalian homologs of the Drosophila PcG protein Psc. They are 
characterized by a highly conserved RING finger domain which is probably is involved in 
the interaction with other PcG proteins (Kyba and Brock 1998). At least 6 different Pcgf 
paralogs have been found in the mammalian genome (Pcgf1-6). As mentioned earlier, 
each of them is associated with a distinct PRC1 type that occupies different genomic loci 
(see Tab.1 and chapter 4.2.2). As shown by several studies, Pcgf1, Pcgf2 and Pcgf4 
mediate the ubiquitination of H2AK119 by targeting Ring1B to chromatin (Wu et al. 
2008; Wu et al. 2013). In addition, Pcgf6 was shown to directly interact with H3K4me3 
demethylase Jarid1d and regulate its enzymatic activity (Lee et al. 2007). Pcgf2 and 
Pcgf4 are the most characterized Pcgf paralogs that are essential for maintenance of the 
appropriate expression of Hox cluster genes. Further, Pcgf2 and Pcgf4 regulate 
differentiation and self-renewal of hematopoietic stem cells (HSCs) as well as 
carcinogenesis and progression of gastric cancer in a reciprocal manner (Kajiume et al. 
2009; Zhang et al. 2010), providing evidence for distinct biological functions of different 
PRC1 types. Notably, beside Pcgf2 and Pcgf4, Pcgf1 was also shown to regulate 
differentiation and self-renewal of hematopoietic cells (Ross et al. 2012). Furthermore, 
while Pcgf4 is hardly detectable in ES cells, its forced expression promoted ES cells to 
differentiate toward hematopoietic lineages (Ding et al. 2012). These data lead to the 
question whether other Pcgf paralogs, Pcgf3, Pcgf5 or Pcgf6, also possess regulatory 
functions during hematopoietic development.  
 
4.2.5 PRC1 components in hematopoiesis  
Beside their functions in ES cells, polycomb complexes are required for hematopoietic 
development. Extensive investigations were made to reveal the roles of PRC2 and PRC1 
in hematopoietic stem cells (HSCs). PRC2 and PRC1 components, in particular Pcgf2 and 
Pcgf4, have opposing regulatory roles in HSCs (Majewski et al. 2010). While PRC2 
restricts the activity of HSCs and hematopoietic progenitors, Pcgf2 and Pcgf4 are 
required for the self-renewal and repopulating capacity of HSCs (Majewski et al. 2010). 
In addition, as demonstrated by a very recent study, the PRC1 subunit Cbx7 preserves 
HSC self-renewal by repressing progenitor-specific genes (Klauke et al. 2013). 
Therefore, Cbx7 is required for the maintaining the balance between self-renewal and 
differentiation of HSCs (Klauke et al. 2013). In comparison to the knowledge about 
polycomb functions in HSCs, less information is available about the role of PRC1 during 
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early embryonic hematopoiesis. As demonstrated in a recent study, loss of the PRC1 
core-subunits Ring1a/b in ES cells caused up-regulation of hematopoietic regulators 
such as Runx1 (Mazzarella et al. 2011). Further, Ring1b was shown to bind to promoters 
of neural genes in EB-derived cells that carried markers for hemangioblast, a common 
precursor of hematopoietic and epithelial lineages. Deletion of Ring1b in these cells 
caused overt expression of neural genes and blocked the in vitro generation of 
hematopoietic colonies (Mazzarella et al. 2011). These results suggest that PRC1 activity 
is required for the appropriate early hematopoietic development. One of the open 
questions is whether the loss of other PRC1 components in ES cells, e.g. Pcgf paralogs, 
would affect ES cell-derived hematopoietic development. 
 
4.3 Scientific aim and strategy   
The multi-protein complex PRC1 acts as a key-regulator for transcriptional silencing. 
Multiple paralogs of each PRC1 core subunit exist in mammals. Various combinations of 
different subunits lead to the significant diversity of PRC1 subtypes with potentially 
distinct functions. 
As a part of PRC1, Pcgf paralogs are involved in regulating self-renewal and 
differentiation of stem cells, including ES cells and adult stem cells. The relevance of the 
Pcgf paralog Pcgf6 for the maintenance of ES cell pluripotency and chromatin biology 
has so far not been addressed. A molecular analysis of Pcgf6 which is active in ES cells 
will improve our understanding of PRC1 function in cellular memory formation, ESC 
pluripotency and differentiation. Here I studied the function Pcgf6 via inducible shRNA-
targeted knockdown in ES cells. The data will be instrumental to generate a 
comprehensive picture of the functional framework of Pcgf paralogs. I expect this 
analysis to provide important new insight into the regulatory circuitry of ES cells. 
 
 
 
 
 
 
 
 
 
21 
 
5 Results 
5.1 The Pcgf paralog Pcgf6 is highly expressed in ES cells  
To characterize the tissue- and cell type-specific gene expression of Pcgf paralogs, qRT-
PCR analyses on various murine embryonic and adult cell and tissue types were 
performed. As shown in Figure 1A, while Pcgf1 and Pcgf4 were highly expressed in 
murine embryonic fibroblasts (MEFs) and neural stem cells (NSCs), high transcription 
levels of Pcgf4 (Bmi1), Pcgf5 and Pcgf6 were found in adult testis. In bone marrow (BM), 
all Pcgf paralogs were detected at low levels. In ES cells (lines: OG2 and V6.5), Pcgf6 was 
expressed at notably higher expression compared to the other paralogs (Figure 1A). To 
determine whether the gene expression pattern of Pcgfs changes upon ES cell 
differentiation, Pcgf1-6 expression was monitored in undifferentiated and 
differentiating ES cells. As shown in Figure 1B, gene expression of Pcgf1 and Pcgf6 
decreased with progressing time of differentiation. Noticeable was the expression of 
Pcgf6 as its expression declined while ES cells differentiate. In contrast, expression of 
Pcgf4 and Pcgf5 increased up to 6-fold following ES cell differentiation. For Pcgf2 and 
Pcgf3 no obvious change in gene expression was observed. In parallel, Pcgf6 expression 
levels were determined in blastocyst. As shown in Figure 1C, the Pcgf6 transcript level in 
blastocysts is similar to ES cells. Pcgf6 transcripts were also detected in fetal tissues 
(Figure 1C). In adult tissues, Pcgf6 was expressed at low levels, except in testis (Figure 
1C). Taken together, the gene expression profile of Pcgf1-6 suggested specific functions 
of Pcgf6 in blastocyst stage embryos, in ES cells and testes.  
To further investigate whether Pcgf6 contributes to the maintenance of ES cell 
pluripotency, we specifically knocked down Pcgf6 in murine ES cells by using shRNAs 
with inducible expression (Figure 2A). For specific shRNA knockdown, 2 independent 
shRNA sequences were chosen from the data bank “The RNAi consortium” 
(http://www.broadinstitute.org/rnai/public/), targeting the protein coding region or the 3 -´
UTR of the Pcgf6 mRNA (Figure 2D). For monitoring changes in ES cell pluripotency or 
differentiation upon gene knockdown, OG2 ES cells (Szabo et al. 2002; Do and Scholer 
2005) carrying an Oct4 promoter-driven eGFP transgene derived from OG2 mice were 
used.  
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Figure 1: qRT PCR analyses for the expression of Pcgf paralogs. Relative expression levels of Pcgf1-6 
A) in different cell types and B) in undifferentiated ES cells and during ES cell differentiation. Expression 
level in undifferentiated ES cells was set to 1. C) Relative expression levels of Pcgf6 in different murine 
tissues. Expression was assayed by qRT-PCR. Shown are quantitative comparisons relative to Hprt 
expression, using the 2−ΔΔT method. n=3 
 
 
5.2 Generation of inducible Pcgf6 shRNA ES cells 
To generate cells with specific and inducible knockdown of Pcgf6 in ES cells, we used the 
RMCE (recombinase-mediated cassette exchange) vector approach with site-directed 
integration of a shRNA expression cassette in a previously modified genomic locus. In 
short: the rosa26 locus was modified by the acceptor vector pTT5 that is than exchanged 
by the donor vector pINV7 via Flp-mediated RMCE.  The pINV7 vector contains a shRNA 
expression cassette that can be induced by doxycyclin, and is silenced in absence of 
doxycyclin (Figure 2A)(Seibler et al. 2005; Seibler et al. 2007). In this two-step process, 
the pTT5 vector was first inserted into the wild type rosa26 locus (rosa26(wt)) of OG2 
ES cells via homologues recombination (Figure 2B, top). Following hygromycin 
selection, 60 ES cell clones were isolated and expanded. 3 positive clones (pTT5 clone 
#A2, #A7, #A15) carrying a modified rosa26 locus (rosa26(RMCE)) were identified by 
PCR using genomic DNA and primers spanning genomic and pTT5 vector sequences 
(Figure 2B, bottom). Based on ES cell morphology and overall appearance, the pTT5 ES 
cell clone #A2 was selected for further experimentation.  
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In a second step shRNA carrying pINV7 vectors for dox-mediated shRNA gene 
expression were inserted into the modified rosa26 locus of pTT5 ES cell clone #A2 via 
Flp-mediated RMCE (Figure 2C, top). After 6 days of G418 selection, clones were isolated 
and expanded. To confirm successful RMCE, clones carrying shRNA sequences (shRNA 
ES cell clones) were analyzed by PCR using genomic DNA and primers spanning genomic 
and pINV7 vector sequences. All analyzed shRNA ES cell clones were positive for the 
exchanged gene cassette (rosa26(RMCE exchanged). Examples from PCR analysis of a 
clone carrying shRNA1 (pTT5A2-pINV7-Pcgf6_2 clone 2) or shRNA2 (pTT5A2-pINV7-
Pcgf6_3 clone 1) are shown in Figure 2C. To assess specific knockdown, a scrambled 
control shRNA sequence that is not complementary to any known transcript was used 
for RMCE. Using this sequence scrambled shRNA ES cell clones (pTT5A2-pINV7-
Scrambled clone 1 or scrambled shRNA ES cell clone) were generated following the 
same procedure as described for the Pcgf6 shRNA ES cell clones.  
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Figure 2: Inducible shRNA knockdown in OG2 ES cells. A) Left: overall structure of Flp-mediated RMCE 
(recombinase-mediated cassette exchange). Right: principle of doxycycline (dox)-induced shRNA 
expression. B) Upper panel: insertion of pTT5 vector (rosa26 targeting vector) into the wild type rosa26 
locus (rosa26(wt)) via homologous recombination. Lower: PCR on genomic DNA to indentify positive 
clones (pTT5 clone #A2, 7 and 15). zsgreen: fluorescence protein zsgreen; PGK-Hyg: PGK promoter-driven 
hygromycin transgene; CAGGS-FLP: CAGGS promoter and Flp gene for constitutive expression; F3/FRT: 
Flp recognition sites; ‘X’: insertion point within the rosa26 locus. P1-L, P1-R: PCR primers, C) Upper panel: 
insertion of pINV7 exchange vector into the rosa26(RMCE) locus via Flp-mediated RMCE. After G418 
selection, positive clones (pTT5-A2PINV7-Pcgf6a, pTT5-A2PINV7-Pcgf6b) carrying the exchanged gene 
cassettes (rosa26RMCE (exchanged)) were identified by PCR. H1: H1 promoter; shRNA: shRNA sequences; 
∆5 n´eoR: truncated neoR gene; pA: polyA signal; SA: splice acceptor site; F3-L, F3-R: PCR primers. (D) 
Structure of Pcgf6 mRNA and target sits of shRNAs.  
 
5.3 Knockdown efficiency of Pcgf6-shRNAs  
To identify shRNA ES cell clones with maximum knockdown, 6 clones carrying shRNA1 
or shRNA2 were isolated and treated with dox for 6 days or left untreated. Subsequently, 
knockdown efficiencies were quantified using qRT-PCR analyses. As shown in Figure 3A, 
pTT5A2-pINV7-Pcgf6_2 clone 2 carrying shRNA1 (further on referred to as ES cell clone 
shRNA1) and pTT5A2-pINV7-Pcgf6_3 clone 1 carrying shRNA2 (further on referred to as 
ES cell clone shRNA2) possessed the highest knockdown efficiency and were therefore 
chosen for subsequent analysis. 
To study the shRNA-induced knockdown kinetics, Pcgf6 transcript levels were assessed 
upon dox treatment. In addition, the reversibility of knockdown upon dox withdrawal 
was tested. For these purposes, undifferentiated ES cell clones shRNA1, shRNA2 and 
Scrambled shRNA were treated with dox for 0, 1, 3, 5 or 6 days or left untreated for the 
corresponding time points. For a fraction of cells dox treatment was withdrawn after 6 
days and cells were left untreated for additional 6 days to monitor reversibility of the 
knock down (see also schematic representation of work flow in Figure 3B). As shown in 
Figure 3C, both dox-treated shRNA1 and shRNA2 ES cells showed up to 80% reduction 
of Pcgf6 transcript levels while Pcgf6 transcript levels in untreated or scrambled shRNA 
ES cells remained unaltered. Further, 6 days after withdrawal of dox, the dox induced 
knockdown of Pcgf6 was reversed (Figure 3C).  
Because Pcgfs share conserved domains in their protein sequences, potential cross-
targeting of Pcgf6 shRNAs was assessed by qRT-PCRs specific for Pcgf paralogs. As 
shown in Figure 3D, expression levels of Pcgf1 – 5 remained unaltered following Pcgf6 
knockdown, indicating that the Pcgf6 shRNAs did not cross-react with paralogs of Pcgf6. 
Taken together, these results indicate successful generation of specific, inducible and 
reversible knockdown of Pcgf6 in OG2 ES cells by 2 independent shRNAs.  
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Figure 3: Knockdown of Pcgf6: efficiency and kinetics. A) Relative gene expression of Pcgf6 in shRNA1 
(left panel) and shRNA2 (right panel) ES cell clones, treated with dox for 6 days or in untreated cells, 
assayed by qRT-PCR. Red boxes indicate the ES cell clones chosen for subsequent analyses. Shown are 
relative Hprt-normalized quantitative comparisons, using the 2−ΔΔT method. Expression levels in untreated 
shRNA-ES cells were set to 1. n=3. B) Experimental design for analyzing knockdown kinetics: 
undifferentiated ES cells were treated with dox for different days or were left untreated. Clones that were 
treated with dox for 6 days were further cultured for 6 days following dox withdrawal. C) Knockdown 
kinetics of both shRNAs or of scrambled shRNA (Scramb) ES cells assayed by qRT-PCR. Shown are relative 
Hprt-normalized quantitative comparisons using the 2−ΔΔT method. Expression levels in untreated shRNA-
ES cells (day 0) were set to 1. n=3. D) Relative gene expression of Pcgf1 – 6 in untreated or dox-treated 
shRNA 1, shRNA2 and scrambled shRNA (Scramb) ES cell cultures. Shown are relative Hprt-normalized 
quantitative comparisons, using the 2−ΔΔT method. Expression levels in untreated shRNA1 ES cells were set 
to 1. n=3.  
 
 
5.4 Pcgf6 knockdown reduces ES cell colony forming ability 
Upon Pcgf6 knockdown, ES cells could be maintained in culture without showing 
evidence of morphological changes unless the colonies of dox-treated shRNA1 and 
shRNA2 ES cells were smaller (Figure 5B upper panel). However, dox-treated shRNA1 
and shRNA2 ES cells showed a reduction in cell number increase. To quantify this 
observation, 5x105 ES cells (shRNA1, shRNA2 and scrambled) were plated +/- dox 
27 
 
treatment. After 2 days, cell numbers were determined and 5x105 cells were plated into 
new cultures. This procedure was repeated for 18 days as illustrated in Figure 5A. Cell 
numbers were determined by counting and plotted against time. As shown in Figure 5B 
(lower panel), reduced cell numbers in shRNA1 and shRNA2 ES cell cultures were 
observed upon dox treatment. Compared to untreated or treated scrambled ES cell 
cultures treated shRNA 1, shRNA2 ES cell cultures slowed down cell number increase 
over a period of 6 days when shRNA 1, shRNA2 ES cell cultures reached a stable plateau 
of reduced cell numbers. To determine whether the reduction in cell numbers was 
paralleled by changes in ES cell pluripotency, dox-treated or untreated shRNA1, shRNA2 
and scrambled shRNA-ES cell cultures were stained for alkaline phosphatase (AP) 
activity (Fig5A). Under standard ES cell culture conditions, undifferentiated ES cells 
grow in uniform and tightly compacted multicellular colonies with high expression of 
membrane alkaline phosphatase (AP). AP activity is considered to be a marker for 
pluripotency (Wobus et al. 1984). As shown in Figure 5C (upper panel), both dox-
treated and untreated ES cells formed AP-positive colonies with ES cell-typical 
morphology. However, in dox-treated shRNA1 or shRNA2 ES cell cultures, reduced total 
colony numbers were counted. In contrast, colony numbers in untreated cultures 
remained unchanged compared to scrambled shRNA cultures (Figure 5C, lower panel), 
indicating a reduction in ES cell colony forming ability upon Pcgf6 knockdown.  
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Figure 4. Reduced ES cell colony formation upon Pcgf6 knockdown. A) Experimental design: ES cells 
were plated at a density of 5x105 cells per 6cm-plate, treated with dox or left untreated. Life cell numbers 
were determined by Trypan blue staining every 2 days for a period of 18 days. AP-staining was performed 
on day 6 +/-dox. B) Representative colony morphology of shRNA1-ES cell cultures on day 6 +/-dox (upper 
panel). Numbers of shRNA1, shRNA2 and Scrambled shRNA-ES cell cultures +/- dox are shown in the 
diagram (lower panel). n=3. C) Numbers of AP+ colonies in undifferentiated ES cell cultures. *, p<0.01; **, 
p<0.001; n=3. Representative pictures of AP
+
 colonies in shRNA1 ES cell cultures (+ or – dox). Light 
microscopy. Scale bare: 200µm. n=3. 
 
5.5 Apoptosis rate, cell cycle distribution and proliferation were not altered 
upon Pcgf6 knockdown 
To investigate whether the reduction of cell numbers, shown in the previous chapter, 
was a consequence of altered apoptosis rate, cell cycle phase distribution or due to a 
proliferative defect in dox-treated shRNA ES cells, these parameters were analyzed 
(Figure 5A). The number of apoptotic cells was quantified by AnnexinV/7AAD staining. 
No significant differences in the frequencies of AnnexinV positive cells were observed in 
dox-treated or untreated shRNA ES cell cultures (Figure 5B). Further, cell cycle phase 
distributions was analyzed by propidium iodide (PI) staining which showed no 
differences in dox-treated or untreated shRNA ES cell cultures (Figure 5C). Finally, cell 
proliferation in dox-treated or untreated shRNA ES cell cultures was quantified based on 
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BrdU incorporation during DNA synthesis in replicating (cycling) cells. As shown in 
Figure 5D, no significant differences in BrdU incorporation rate was detected, indicating 
no changes in cell proliferation. In summary, Pcgf6 knockdown caused no significant 
changes in apoptosis rate, cell cycle distribution or cell proliferation.  
 
Figure 5. Analyses for apoptosis, cell cycle distribution and proliferation. A) Experimental design. ES 
cells were treated with dox for 6 days or left untreated before analyses. B) Apoptosis rate in shRNA-ES cell 
cultures +/- dox was evaluated by AnnexinV/7AAD staining followed by flow cytometry (FACS) analysis. 
Representative FACS profiles (upper panel) show the analyzed cell populations, and AnnexinV+ cells in 
quadrant A2. Diagram (lower panel) shows the percentages of AnnexinV+ cells in shRNA1, shRNA2 and 
Scrambled shRNA-ES cell cultures +/- dox. Statistical significance from three independent experiments is 
expressed in p-values. C) Cell cycle distribution by propidium iodide (PI) staining followed by FACS 
analysis. Data were analyzed with ModFit software. Diagram shows the percentages of cells in different 
phases of the cell cycle in shRNA1, shRNA2 and Scrambled shRNA-ES cell cultures +/- dox. n=3. D) Flow 
cytometric analysis of BrdU incorporation in shRNA1, shRNA2 and Scrambled shRNA-ES cell cultures +/- 
dox. Cells were incubated with BrdU for different times (up to 6 h). Percentages of BrdU+ cells were 
determined by FACS using an anti-BrdU antibody. n=3.  
 
5.6 Global Histone modifications in ES cells upon Pcgf6 knockdown  
All Pcgf paralogs directly interact with the PRC1 core-enzyme Ring1B that catalyzes the 
ubiquitination of histon H2A (H2Aub) (Gao et al. 2012). On the functional level, loss of 
Pcgf4 leads to global reduction of H2Aub, suggesting a critical role for Pcgf4 in H2A 
ubiquitination (Cao et al. 2005). To address the consequences of Pcgf6 knockdown on 
the global level of H2Aub or other histone modifications in ES cells, Western blot 
analyses were performed using specific antibodies. I further was interested in the global 
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level of H3K4me3 because Pcgf6 interacts with Jarid1d in somatic cells, and it was 
shown to enhance its H3K4 demethylase activity (Lee et al. 2007). Also, global levels of 
known Polycomb associated histone modifications, H3K9me3 and H3K27me3, were 
analyzed. In addition, because histone deacetylases 1 (Hdac1) and 2 (Hdac2) were 
reported being interaction partners of Pcgf6 (Gao et al. 2012), global levels of H3- (H3ac) 
and H4-acetylation (H4ac) were determined. For Western blot analyses, whole cell 
lysates were collected from shRNA1, shRNA2 and scrambled shRNA ES cell cultures +/-
dox for 6 days (Figure 6A). As shown in Figure 6B, no alterations in global levels of 
H2Aub, H3ac, H4ac, H3K4me3, H3K9me3 or H3K27me3 histone modifications were 
observed. 
 
Figure 6. Global levels of selected histone modifications.  A) Experimental design:  ES cells were 
treated with dox for 6 days or left untreated. Whole cell lysates were prepared. B) Representative 
Western blot analysis for global levels of histone modifications in undifferentiated shRNA-ES cells +/- dox.  
Loading controls: histone H3 and H4.  n=3.  
 
5.7 Pcgf6 knockdown increases expression of developmental and testis specific 
genes in ES cells 
PRC1 plays essential roles in maintaining ES cell pluripotency. Loss of PRC1 functions 
causes de-repression of differentiation-associated genes (see in Introduction).  As a part 
of PRC1.6 complex, Pcgf6 was shown to directly interact with Ring1B, the core enzyme 
of PRC1 (Gao et al. 2012). Together with the observation that Pcgf6 is highly expressed 
in undifferentiated ES cells (Figure 1A, C), global changes of gene expression in ES cells 
was assumed upon Pcgf6 knockdown. To address this assumption, global gene 
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expression patterns were compared between shRNA1, shRNA2 and scrambled ES cells 
+/- dox treatment using cDNA microarray analysis (Affymetrix) (Figure 7A, B). Gene 
expression levels were normalized with the RMA algorithm (Irizarry et al. 2003). 
Expression values from the microarray analysis confirmed that Pcgf6 was knocked 
down in dox-treated shRNA1 or shRNA2 ES cell cultures, and as expected, not in dox-
treated scrambled shRNA cultures (Figure 7B). Further, the expression values indicated 
that the most of the differentially expressed transcripts after Pcgf6 knockdown showed 
up-regulation (Figure 7B). Compared to untreated shRNA1 or shRNA2 or scrambled 
shRNA ES cell cultures, microarray analysis revealed 290 transcripts hereunder 59 
annotated genes with greater than 2-fold altered expression levels in dox-treated 
shRNA1 ES cell culture, 402 transcripts hereunder 71 annotated genes in dox-treated 
shRNA2 ES cell culture, and 190 transcripts hereunder 22 annotated genes in dox-
treated scrambled shRNA ES cell culture (Figure 7C). Among these differentially 
expressed transcripts, 36 annotated genes in dox-treated shRNA1 and shRNA2 ES cell 
cultures overlapped (Figure 7C). Except for Pcgf6 which was knocked down, all other 35 
genes showed up-regulated expression (Data not shown). None of the 35 genes was 
found differentially expressed in dox-treated scrambled shRNA cultures (Figure 7C). 
Gene ontology (GO) analysis of the 35 overlapping genes was performed using the 
DAVID classification tool (Huang da et al. 2009b; Huang da et al. 2009a). The analysis 
revealed, besides categories like “developmental protein” or “differentiation”, strong 
associations with “reproduction” or “spermatogenesis” (Figure 7D). To access whether 
the altered gene expression following Pcgf6 knockdown overlaps with those after the 
loss of PRC1 function or the loss of the PRC1.6 subunit L3mbtl2, up-regulated or de-
repressed genes in ES cells were compared between Pcgf6 knockdown, Ring1A/B 
double knockout (dKO) (Endoh et al. 2008) or L3mbtl2 knockout (KO)(Qin et al. 2012) 
(Figure 7E). In total, 12 de-repressed genes were shared by Pcgf6 knockdown and 
Ring1A/B dKO; and 16 de-repressed genes were shared by Pcgf6 knockdown and 
L3mbtl2 KO. In parallel, 6 genes were found in overlap of all 3 phenotypes. Notably, all 6 
genes are involved in spermatogenesis (Dazl, Mael, Piwil2 and Taf7l) or possess testis-
specific expression (Stk31, Tex13) (Figure 7E). 
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Figure 7: Global gene expression analysis following Pcgf6 knockdown. A) Experimental design. ES 
cells were treated with dox for 6 days or left untreated before cDNA microarray analysis (Affymetrix). B) 
Pair-wise scatter plot of expression values from the microarray analysis. shRNA1 +dox versus –dox (top), 
shRNA2 +dox versus –dox (middle) and Scrambled +dox vs –dox (bottom). Black lines indicate 2-fold 
changes in expression values. Over-expressed transcripts are indicated by red and under-expressed 
transcripts by blue. C) Venn diagram shows the overlap of annotated genes with altered expression (fold 
change ≥2) in shRNA1, shRNA2 and Scrambled shRNA ES cell cultures +/- dox. D) Gene ontology (GO) 
categories associated with the overlapping and up-regulated genes in shRNA1 and shRNA2 ES cell 
cultures +/- dox. GO classification was performed with the DAVID classification tool. E) Venn diagram 
shows the overlap of up-regulated genes in Pcgf6-knockdown (KD), Ring1A/B double knockout (dKO), 
and L3mbtl2 KO ES cells. Red box shows the overlapping genes.  
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Pcgf6 knockdown in undifferentiated and differentiating ES cells increases the 
expression of mesodermal marker genes  
Pcgf paralogs Pcgf1, Pcgf2 and Pcgf4 are involved in the regulation of hematopoietic 
development (Park et al. 2003; Kajiume et al. 2004; Ross et al. 2012). To address 
whether Pcgf6 also possesses regulatory functions during hematopoietic development, 
the consequences of Pcgf6 knockdown on ES cell mesodermal and hematopoietic 
differentiation were analyzed. For this purpose, gene expression of pluripotency 
markers, lineage markers including markers for early mesoderm, hematopoietic 
development, endoderm and ectoderm, and also PRC1 and PRC2 members were 
characterised following Pcgf6 knockdown using qRT-PCR. Analyzed were ES cell 
cultures (shRNA1, shRNA2 and scrambled shRNA), dox-treated for 6 days or left 
untreated, and EBs at day 3.5 of differentiation, a time point which approximately marks 
the in vitro onset of early mesodermal gene expression (Figure 8A) (Pearson et al. 
2010). 
Upon Pcgf6 knockdown, gene expression of pluripotency markers Oct4, Nanog and Sox2 
showed slight down-regulation in undifferentiated ES cells (Figure 8B, left), but no 
differences after 3.5 days of differentiation in EBs (Figure 8B, right). In contrast, 
transcripts of early mesodermal genes such as T and Tie-2 were up-regulated in both 
shRNA ES cells and in day 3.5 EBs. Gene expression of early mesoderm markers such as 
Runx1 and Flk1 showed upon knockdown no alterations in ES cells, but were up-
regulation in day 3.5 EBs. In addition, HoxA3, HoxA7 and HoxA9, homeobox genes that 
previously have been shown to be involved in hematopoietic development (So et al. 
2004; Lebert-Ghali et al. 2010; Mahdipour et al. 2011) also showed elevated 
transcription in day 3.5 EBs upon Pcgf6 knockdown. In contrast, expression of 
endodermal gene Sox17 and ectodermal genes Nestin and Sox21 were down regulated 
in both ES cells and in day 3.5 EBs. In addition, gene expression of PRC1 subunits 
including Pcgf1-5, and subunits that were shown to interact with Pcgf6, such as Ring1B 
and L3mbtl2, were analyzed. In both undifferentiated ES cells and day 3.5 EBs, the 
expression of these genes remained unaltered following Pcgf6 knockdown. Also, 
alterations in gene expression of PRC2 components were not observed.  
Taken together, upon Pcgf6 knockdown, gene expression analyses revealed altered 
expression of lineage markers in undifferentiated ES cells and during differentiation. In 
Pcgf6 knockdown ES cells, expression of early mesoderm genes such as T were up-
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regulated whereas endoderm genes, e.g. Sox17, or ectoderm genes, e.g. Sox21, were 
down regulated.  
 
 
Figure 8. qRT PCR analyses for the expression of pluripotency markers, lineage markers, PRC1 and 
PRC2 members. A) Experimental design. ES cells were treated with dox for 6 days or left untreated 
before EB differentiation. Dox-treatment proceeded during EB differentiation. B) Relative gene expression 
levels of pluripotency markers, lineage markers, PRC1 and PRC2 members in undifferentiated ES cells and 
in day 3.5 RBs. Shown are quantitative comparisons relative to Hprt and Rpl113a expression, using the 
2−ΔΔT method. Untreated shRNA1 cultures (shRNA -dox) were set to 1. n=1. 
35 
 
5.8 Pcgf6 knockdown in ES cells caused transiently increased up-regulation of 
early mesodermal/hematopoietic marker genes during ES cell differentiation 
As Pcgf6 is down-regulated during ES cell differentiation (Figure 1B), the next question 
was whether the differentially expressed genes in day 3.5 EBs, caused by Pcgf6 
knockdown, retained their altered expression levels during ES cell differentiation. To 
answer this, expression levels of Pcgf6, Oct4 and 3 early mesodermal/hematopoietic 
marker genes were analyzed at different time points of ES cell differentiation +/- dox 
(Figure 9A). As expected, Pcgf6 transcript levels were knocked down in dox-treated 
shRNA1 and shRNA2 ES cell cultures (Figure 9B). In addition, while Oct4 transcript 
levels in dox-treated cultures showed no alterations compared to untreated and 
scrambled shRNA cultures, expression of early mesodermal markers T, Fkl1 and Runx1 
were temporally increased in dox-treated shRNA1 and shRNA2 cultures at day 3.5 of 
differentiation. On day 6 of differentiation, expression of these markers in dox-treated 
and untreated cultures was similar. Taken together, early mesodermal markers T, Flk1 
and Runx1 were temporally up-regulated during ES cell differentiation.  
 
Figure 9. qRT PCR analyses for the expression of early mesodermal/ hematopoietic markers A) 
Experimental design. ES cells were treated with dox for 6 days or left untreated before set into EB 
differentiation. Dox-treatment proceeded during EB differentiation. B) Relative expression levels of Pcgf6, 
Oct4 and early mesodermal/hematopoietic markers in undifferentiated ES cells and in EBs. Expression 
was assayed by qRT-PCR. Shown are quantitative comparisons relative to Hprt expression, using the 2−ΔΔT 
method. n=3. 
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5.9 Pcgf6 knockdown increases ES cell hemangioblast differentiation 
To address whether upon Pcgf6 knockdown the altered gene expression affects lineage 
outcomes in differentiating ES cell cultures, the development of hemangioblasts, which 
are common precursors of both hematopoietic and endothelial lineages, was probed. 
During development of hemangioblasts, the vascular endothelial growth factor (VEGF) 
receptor Flk-1 plays a key role (Shalaby et al. 1997). Flk1+ cells rise after 3 to 4 days of 
EB differentiation. These cells were shown to be the in vitro equivalents of 
hemangioblasts (Kennedy et al. 1997; Choi et al. 1998; Faloon et al. 2000). In 
methylcellulose cultures (MC) these cells can generate blast colonies (blast colony-
forming cells, BL-CFC). Before the onset of Flk1 expression, the early mesoderm marker 
CD40 is expressed on mesodermal precursor cells. At the hemangioblast stage, Flk1 and 
CD40 are co-expressed (Pearson et al. 2010). To monitor ES cell-derived hemangioblast 
development under Pcgf6 knockdown, I analyzed cell surface expression of Flk1 and 
CD40 in day 3.5 EB cells (shRNA1, shRNA2 and scrambled shRNA ES cells) +/- dox 
(Figure 10A). As shown in Figure 10B, of day3.5 EBs the frequency of Flk1+ cells and 
CD40+ cells increased upon dox-induced Pcgf6 knockdown. To monitor the exit from 
pluripotency, ectopic expression of an Oct4-eGFP transgene in OG2 ES cells was 
measured using FACS (Figure 10B). As expected, Flk1+ cells or CD40+ cells were Oct4-
eGFP negative.   
To analyze BL-CFC frequencies, single cell suspensions of EBs at different time points of 
differentiation were cultured in MC cultures supplemented with growth factors that 
favor endothelial and hematopoietic differentiation (Figure 10A). As shown in Figure 
10C, both dox-treated and untreated EBs differentiating for 4 days showed the highest 
numbers of BL-CFCs. However, dox-treated shRNA1 and shRNA2 EB cells differentiating 
for 2.5, 3.5 or 4 days generated significantly elevated BL-CFC numbers compared to dox-
treated scrambled control.  BL-CFC frequencies in dox-treated shRNA cultures ranges 
from 600 to 800 per 5x104 cells derived from 4 days old EBs while untreated day 4 EBs 
generated on average 500 BL-CFCs per 5x104 cells. 
In summary, Pcgf6 knockdown in ES cells caused increased frequencies of Flk1+ and 
CD40+ cells at day 3.5 of EB differentiation that was associated with elevated levels of 
BL-CFC formation. These results suggest a negative regulatory role of Pcgf6 for ES cell 
hemangioblast formation.  
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Figure 10. Pcgf6 knockdown increases blast colony formation. A) Experimental design. ES cells were 
dox-treated for 6 days or left untreated before differentiation into EBs was induced. After 3 days of 
differentiation, hemangioblast markers Flk1 and CD40 were analyzed, or EB cells were seeded into 
methylcellulose cultures containing growth factors for hemangioblast development. After 3-5 days blast 
colonies were counted. B) Flk1 and CD40 expression in day 3.5 EB cultures +/- dox. Analysed were 
shRNA1, shRNA2 and scrambled ES cells. Blotted are Flk1/Oct4-eGFP and CD40/Oct4-eGFP signals. 
Indicated are Oct4-eGFP-/Flk1+ and Oct4-eGFP-/CD40+ cell frequencies. A representative analysis is 
shown. n=3. C) Numbers of blast colonies generated by day 2 to day 6 EBs (shRNA1, shRNA2 and 
scrambled shRNA ES cells +/- dox). n=3. Insert shows a typical blast colony. *, p<0.01 
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5.10 Pcgf6 knockdown enhances ES cell differentiation towards hematopoietic 
lineages 
The augmented development of hemangioblasts upon Pcgf6 knockdown prompted me 
to analyze the hematopoietic capacity of EB cultures that derived from Pcgf6 
knockdown-ES cells. Hematopoietic progenitors develop sequentially within EBs. A first 
step is represented by transient BL-CFCs that are followed by a primitive erythroid wave 
at day 4 to day 8 of differentiation (Keller et al. 1993). Definitive erythroid and myeloid 
progenitors develop shortly after primitive erythroid progenitors. To determine 
whether knockdown of Pcgf6 promotes hematopoietic progenitor cell development, 
cells from 6, 7 or 9 days old EBs (shRNA1, shRNA2 and scrambled ES cells) +/- dox were 
replated into MC medium containing a cocktail of growth factors for hematopoietic 
differentiation (Figure 11A). As shown in Figure 11B, significantly increased numbers of 
primitive erythroid (BFU-E) and multipotential colonies (CFU-GM) were observed in 
dox-treated shRNA1 and shRNA2 cultures. Representative morphology of colony types is 
shown in Figure 11C. 
 
Figure 11. Hematopoietic development upon Pcgf6 knockdown. A) Experimental design: ES cells were 
treated with dox for 6 days or left untreated before differentiation into EBs. After 7 days of differentiation, 
EB cells were seeded into MC cultures containing hematopoietic growth factors (mSCF, mTPO, hEPO, mIL-3, 
mIL-6 and mGM-CSF). After 5-6 days hematopoietic colonies were counted. B) Numbers of hematopoietic 
colonies per 10
5
 day 7 EB cells. n = 3. *, p<0.01. C) Representative pictures of CFU-GM- and BFU-E-type 
colonies under phase contrast microscopy.  
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6 Discussion  
The aim of this thesis was to study the function of the Pcgf paralog Pcgf6 via inducible 
shRNA-targeted knockdown in ES cells. In summary, consequences of Pcgf6 knockdown 
include reduced ES cell colony formation, increased expression of differentiation 
associated genes, in particular spermatogenesis-specific and mesodermal genes, and 
increased in vitro ES cell hemangioblast formation and hematopoietic differentiation.                                                  
The results will be further discussed in the following paragraphs.  
 
6.1 Differential gene expression of Pcgf paralogs suggests paralog-specific 
functions 
Paralogs of the Pcgf gene family encode for a group of proteins (Pcgf1-Pcgf6) that 
directly interact with Ring1A and Ring1B, the E3 ubiquitin ligases and subunits common 
to all forms of PRC1 (Gao et al. 2012). At the functional level, Pcgf paralogs define 
distinct types of PRC1 (PRC1.1–PRC1.6) that bind to different target genes (Gao et al. 
2012). In undifferentiated ES cells, several different PRC1 types were reported recently: 
PRC1.1 (PRC1 containing Pcgf1, Rybp, Fbxl10) (Wu et al. 2013), 2 subtypes of PRC1.2 
(PRC1 containing Pcgf2, Rybp or Pcgf2, Cbx7) (Morey et al. 2012; O'Loghlen et al. 2012; 
Tavares et al. 2012) and PRC1.6 (PRC1 containing Pcgf6, Rybp, L3mbtl2) (Qin et al. 
2012). Among these PRC1 types, PRC1.2 binding sites are marked by H3K27me3 which 
is catalyzed by PRC2 (Tavares et al. 2012). In contrast, PRC1.1 and PRC1.6 were shown 
to be functionally independent from the activities of PRC2 (Wu et al. 2013). While 
PRC1.1 requires its co-factor Fbxl10 for target binding (Qin et al. 2012; Wu et al. 2013), 
PRC1.6 shares subunits with the E2F6-complex (Qin et al. 2012), and is likely to interact 
with its target sites through L3mbtl2 (Qin et al. 2012). The existence of multiple PRC1 
types in undifferentiated ES cells points to complex and combinatorial PRC1-dependent 
regulation. Notably, ES cell differentiation is accompanied by alterations in the PRC1 
repertoire. For example, PRC1.2 (containing Pcgf2, Cbx7) is substituted by PRC1.4 
(containing Pcgf4, Cbx2 and Cbx4) (Tavares et al. 2012). Findings in this study 
confirmed this observation by showing alterations in expression levels of Pcgf paralogs 
upon ES cell differentiation (Figure 1B). A down-regulation of Pcgf2 transcripts was not 
observed in this study although a slight reduction on Pcgf2 protein level upon 
differentiation was published (Tavares et al. 2012). This could be explained by cell type 
variance or predominant regulation of Pcgf2 on the translational level. Gene expression 
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analysis of Pcgf paralogs in this study argues for their developmental stage-depended 
functions. In addition, the co-expression of Pcgf paralogs appears to be cell type-specific. 
For example, high expression levels of Pcgf4, Pcgf5 and Pcgf6 were found in adult testis, 
while this combination was not observed in ES cells (Figure 1A). Taken together, 
expression of Pcgf paralogs is cell type-specific and depends on the developmental stage. 
 
6.2 shRNA-based Pcgf6 knockdown in ES cells was inducible and reversible 
To study the functions of Pcgf6 in ES cells stable and specific knockdown of Pcgf6 
transcripts via shRNAs was established in this study. Using a published 2-step-RMCE 
system (Seibler et al. 2005; Seibler et al. 2007), Pcgf6 transcript level was knocked down 
via doxycycline-induced shRNA expression, and it could be restored after withdrawal of 
doxycycline. These results showed that the shRNA-knockdown system was working as 
expected. The controllable knockdown of Pcgf6 via RNA interference (RNAi) in ES cells 
was not only suitable for the in vitro applications in this study, but will provided a basis 
for reproducible in vivo applications via blastocyst injection (Seibler et al. 2007) in 
future studies. In particular, the site-specific insertion of shRNAs into the rosa26 locus 
excluded any unique and irreproducible shRNA expression which can be generated by 
e.g. lentiviral infection (Bahi et al. 2005; Seibler et al. 2007).  
 
6.3 Pcgf6 knockdown led to reduced ES cell colony formation, but did not affect 
ES cell morphology, proliferation, cell cycle distribution or cell survival 
PRC1 is required for the maintenance of ES cell identity. ES cells lacking Ring1A and 
Ring1B (Ring1A/B-dKO ES cells) exhibited decreased proliferation and gradual loss of 
typical ES cell morphology (Endoh et al. 2008). These phenotypes, however, were not 
observed in Ring1B-KO ES cells, indicating compensation by Ring1A and functional 
overlap between the Ring1 paralogs (de Napoles et al. 2004; Endoh et al. 2008). Such 
functional overlap was also observed between different Pcgf paralogs. For example, 
while knockout of Pcgf2 or Pcgf4 in mouse led to partially overlapping phenotypes (van 
der Lugt et al. 1994; Akasaka et al. 1996; van der Lugt et al. 1996; Akasaka et al. 2001), 
mice double deficient for Pcgf2 and Pcgf4 exhibited unique phenotypes (Akasaka et al. 
2001). In this study, knockdown of Pcgf6 did not affect ES cell morphology, proliferation 
or cell cycle phase distribution (Figure 5C, 5D). Only a weak trend towards an increased 
apoptosis rate upon Pcgf6 knockdown was observed (Figure 5B). Considering these 
results together with a possible compensation by other active Pcgf paralogs, Pcgf6 is at 
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least not essential for the regulation of ES cell proliferation, cell cycle distribution or cell 
survival.  
Notably, Pcgf6 knockdown in ES cells resulted in significantly reduced colony numbers 
in this study, paralleled by decreased cell numbers (Figure 4B, C). This was surprising 
because ES cell proliferation, cell cycle phase distribution or apoptosis after Pcgf6 
knockdown did not show significant changes. As shown in several previous studies, 
regulation of intercellular adhesion and colony formation of ES cells involves the Ca2+-
dependent cell-cell-adhesion protein E-cadherin (Larue et al. 1996; Dang et al. 2004; 
Redmer et al. 2011). However, gene expression of E-cadherin in ES cells was not affected 
after Pcgf6 knockdown (Microarray analysis, data not shown), suggesting that Pcgf6 is 
not essential for E-cadherin regulation. Therefore, Pcgf6 may be involved in the 
regulation of ES cell colony formation through other yet unknown mechanisms.  
 
6.4 Pcgf6 is not required for gene expression of other Pcgf paralogs, PRC1 or 
PRC2 core subunits in ES cells 
Loss-of-function studies of Pcgf2 and Pcgf4 in mouse revealed important functions of 
Pcgf paralogs in mammalian development. As Pcgf2 was shown to regulate cell 
proliferation and senescence as an up-stream repressor of Pcgf4 (Guo et al. 2007), Pcgf 
paralogs may regulate each other’s expression. Although there is no evidence so far that 
Pcgf4 directly targets its paralogs, loss of Pcgf4 in MEFs led to up-regulation of Pcgf2, 
Pcgf3, Pcgf5, Pcgf6 but down-regulation of Pcgf1 (Global gene expression analysis in: 
(Kallin et al. 2009)). In this study, altered gene expression of Pcgf1-Pcgf5 were not 
observed upon Pcgf6 knockdown in undifferentiated ES cells (Figure 3D). Further, 
expression of PRC1 or PRC2 core subunits, such as Ring1A and Ring1B or Eed, Ezh2 and 
Suz12, were also not affected in Pcgf6 knockdown ES cells or EBs. In summary, these 
results indicate that Pcgf6 is not involved in the regulation of other Pcgf paralogs or PRC 
core subunits.  
 
6.5 Pcgf6 is involved in regulating expression of pluripotency genes Oct4, Sox2 
and Nanog 
In this study, shRNA mediated knockdown of Pcgf6 led to reduced expression of the 
pluripotency genes Oct4, Sox2 and Nanog in undifferentiated ES cells (Figure 8B, 9B). 
The link between Pcgf6 and pluripotency genes was first reported in a genome-wide 
RNAi screen in mES cells that was setup to identify novel pluripotency factors. In this 
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RNAi screen, Pcgf6 knockdown via 2 different siRNAs led to decreased transcript levels 
of Oct4, Sox2 and Nanog, paralleled by a tendency of knockdown-ES cells to 
spontaneously differentiate (Hu et al. 2009). However, the tendency to spontaneous 
differentiation of Pcgf6 knockdown-ES cells was not observed in this study. Taken into 
account that the knockdown efficiencies of Pcgf6 transcript level were similar in both 
studies (Hu et al. 2009)(Figure 3D), this phenotypic difference may be explained by 
variations in cell culture conditions. For example, unlike in the RNAi screen, ES cells 
were always cultured on MEFs in this study. Taken together, results of this study 
confirmed that Pcgf6 plays a role in ES cell pluripotency by being involved in 
transcriptional regulation of pluripotency genes such as Oct4, Sox2 and Nanog.   
 
6.6 Pcgf6 is required for the repression of differentiation-associated genes and 
spermatogenesis-specific genes 
PRC1 function is essential for maintaining the undifferentiated state of ES cells by 
repressing the expression of differentiation-associated genes (Boyer et al. 2006; Leeb 
and Wutz 2007; Stock et al. 2007; Endoh et al. 2008; van der Stoop et al. 2008; Leeb et al. 
2010). Knockdown of Pcgf6 in ES cells resulted in altered expression of a set of genes 
which were mostly up-regulated or, considering the repressive functions of PRC1, de-
repressed (Figure 7B). The expression pattern of Pcgf6 knockdown-ES cells only 
partially overlapped with expression patterns that were previously described for ES 
cells lacking other PRC1 subunits. For example, ES cells lacking both Ring1A and Ring1B 
(Ring1A/B-dKO ES cells) showed de-repression of several lineage-specific genes. Among 
these genes, only a small set of testis/spermatogenesis genes were also found to be de-
repressed after Pcgf6 knockdown (Figure 7E). Notably, one of these 
testis/spermatogenesis genes, Tex13, was also de-repressed in ES cells lacking the PRC2 
subunit Eed (Schoeftner et al. 2006; Leeb et al. 2010). Eed-KO led to loss of H3K27 
mono-, di- and trimethylation (Montgomery et al. 2005; Montgomery et al. 2007). 
Because PRC1.6 (contains Pcgf6) was reported to act independently of PRC2 (Qin et al. 
2012; Tavares et al. 2012), it is possible that certain genes like Tex13 are targeted by 
multiple PRC1 subtypes.  
Overall the expression pattern overlap between L3mbtl2 KO-ES cells and Pcgf6 
knockdown-ES cells was relatively small (Figure 7E). L3mbtl2 is a PRC1.6 subunit that is 
required for PRC1.6 target binding in ES cells. Loss of L3mbtl2 in ES cells caused de-
repression of genes involved in development, differentiation, spermatogenesis and cell 
43 
 
growth (Gao et al. 2012; Qin et al. 2012). Both Pcgf6 and L3mbtl2 were previously 
identified as members of the PRC1.6, it was therefore unexpected that only less than 
50% of de-repressed genes in Pcgf6 knockdown-ES cells overlap with de-repressed 
genes in L3mbtl2KO ES cells. Also the comparison between the de-repressed genes in 
Ring1A/B-dKO ES cells (Endoh et al. 2008), in L3mbtl2 KO-ES cells (Qin et al. 2012) or in 
Pcgf6 knockdown-ES cells revealed only a small overlap which included 6 
spermatogenesis- or testis-specific genes (Figure 7E). These data suggest that Pcgf6 may 
have non-overlapping functions which are independent from L3mbtl2 or Ring1A/B.  
Interestingly, loss of Pcgf4 in MEFs (Kallin et al. 2009) led to up-regulation of 3 of these 
genes (Dazl, Mael and Tex13) and down-regulation of the other 3 (Piwil2, Stk31 and 
Taf7l). These observations suggest that Pcgf6 may be involved in repressing several 
testis-specific genes in undifferentiated ES cells possibly in concert with other PRC1 
members.  
Another notable observation was the partially opposing alterations in expression of 
pluripotency or lineage-specific genes in L3mbtl2 KO-ES cells and in Pcgf6 knockdown-
ES cells. First, loss of L3mbtl2 did not affect the expression of Oct4 or Nanog in 
undifferentiated ES cells (Qin et al. 2012). Unlike in L3mbtl2 KO-ES cells, the expression 
of Oct4, Nanog and Sox2 was slightly reduced in undifferentiated Pcgf6 knockdown-ES 
cells. Second, endoderm marker Sox17 was down-regulated in both undifferentiated 
Pcgf6 knockdown ES cells and EBs. In contrast, increased expression of Sox17 was 
observed in undifferentiated L3mbtl2 KO-ES cells and Ring1B KO-ES cells (Leeb et al. 
2010; Qin et al. 2012). Third, upon Pcgf6 knockdown, expression levels of mesodermal 
markers T, Flk1 and Runx1 were increased in both ES cells and day 3 EBs. In day 6 EBs, 
T was down-regulated to a similar level as in scrambled control cultures. Also in 
Ring1A/B dKO-ES cells, up-regulation of T was observed (Endoh et al. 2008). In contrast, 
T was down-regulated in undifferentiated L3mbtl2 KO-ES cells, and in day 12 L3mbtl2 
KO-EBs T was aberrantly up-regulated (Qin et al. 2012). Overlapping effects were 
observed on reduced expression of some ectoderm genes in ES cells and EBs, albeit 
different genes were affected upon L3mntl2 KO (e.g. Sox11) or Pcgf6 knockdown (e.g. 
Sox21). Taken together, these data again suggest that Pcgf6 may also function in ES cells 
independently form L3mbtl2 or Ring1A/B. This idea has been supported by the 
following findings: first, Pcgf6 directly interacts with Jarid1d, an H3K4me3 demethylase 
not being reported as a part of PRC1 complexes, in human somatic cells (Lee et al. 2007); 
and second, in contrast to Pcgf6 knockdown-ES cells, the expression of pluripotency 
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genes such as Oct4, Nanog or Sox2 was not down-regulated in Ring1B KO or Ring1A/B 
dKO or L3mbtl2 KO-ES cells (Endoh et al. 2008; Qin et al. 2012).  
 
6.7 Pcgf6 is not required for maintaining the global level of H2AK119 histone 
marks 
A number of studies have demonstrated that mono-ubiquitination of histone H2A at 
lysine 119 is important in PcG-mediated silencing, with Ring1A/B as the E3 ligase in this 
process (de Napoles et al. 2004; Wang et al. 2004; Endoh et al. 2008; Luis et al. 2012). 
Pcgf paralogs Pcgf1, Pcgf2 and Pcgf4 were shown to be involved in Ring1A and Ring1B-
dependent H2AK119 ubiquitination. For example, knockdown of Pcgf1 in ES cells (Wu et 
al. 2013) or knockout of Pcgf4 in somatic cells caused global reduction of H2AK119ub 
levels (Cao et al. 2005). In addition, mutations of Pcgf2 protein sequence led to less 
efficient ubiquitination of nucleosomes in vitro (Elderkin et al. 2007). In this study, 
global alterations of the H2AK119ub levels, as well as levels of other known polycomb-
associated histone modifications, such as H3K4me3, H3K9me3 or H3K27me3 were not 
detected upon Pcgf6 knockdown. One possible explanation is that the detection method 
(Western blot) was probably not sensitive enough because other PRC1 complexes were 
still active while Pcgf6 was knocked down. Nevertheless, it is possible that local 
H2AK119ub levels at promoter regions of Pcgf6 target genes changed after Pcgf6 
knockdown. Future ChIP analysis will address this issue.  
 
6.8 Pcgf6 is involved in maintaining ES cell identity by preventing mesodermal/ 
hematopoietic differentiation 
Pcgf paralogs are involved in self-renewal and differentiation of hematopoietic cells 
(Kajiume et al. 2009; Konuma et al. 2010; Ding et al. 2012; Kajiume et al. 2012). Mutant 
animal models suggested essential functions of Pcgf2, Pcgf4 and Ring1B in adult 
hematopoiesis (van der Lugt et al. 1994; Park et al. 2003; Iwama et al. 2004; Kajiume et 
al. 2004; Oguro et al. 2006; Cales et al. 2008). In addition, Loss of PRC1 subunits Pcgf2, 
Pcgf4, Phc1, Phc2, Ring1A, Ring1B, and Cbx2 cause impaired hematopoietic stem cell 
(HSC) function (Sauvageau and Sauvageau 2010). However, the roles of Pcgf paralogs 
during the initiation of the embryonic hematopoiesis still remain largely unknown. The 
initiation of hematopoiesis in the mouse embryo was believed to take place in the yolk 
sac where blood islands consisting of primitive erythroid cells surrounded by a layer of 
angioblasts develop around day 7.5 of gestation (Moore and Metcalf 1970; Haar and 
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Ackerman 1971). The hypothesis that these progenitors arise from a common precursor, 
the hemangioblast (Sabin 1917; Murray 1932), could be corroborated in later studies 
(Kennedy et al. 1997). New insights in the origins of the hemangioblast were added by 
another study, as hemagioblasts were detected at maximum frequency in the posterior 
streak region of the neural plate-stage mouse embryo (Huber et al. 2004), indicating that 
the initial stages of hematopoietic and vascular commitment take place in the posterior 
primitive streak mesoderm before blood island development in the yolk sac. During in 
vitro differentiation of ES cells, a precursor can be transiently identified within 2 – 4 
days of EB differentiation that generates blast colonies containing both primitive 
hematopoietic and endothelial progenitors (Choi et al. 1998). Because this so-called 
blast colony forming cell (BL-CFC) expresses T-box transcription factor T and Flk-1, and 
shares the same differentiation potential with the hemangioblast, it is considered to be 
the in vitro equivalent of the common precursor (Kennedy et al. 1997; Choi et al. 1998; 
Nishikawa et al. 1998; Ogawa et al. 2001). With progression of differentiation, 
primitive/definitive hematopoietic progenitors appear within 6 to 10 days old EBs. A 
hint that Pcgf paralogs could play roles in the initiation of hematopoiesis was given by a 
recent study (Ding et al. 2012).The authors demonstrated that ectopic expression of 
Pcgf4 in ES cells promoted ES cell derived hematopoietic cell development (Ding et al. 
2012). Using Pcgf6 knockdown-ES cells, regulatory functions of Pcgf6 during ES cell 
derived hematopoietic development were demonstrated in this study. In concert with 
the up-regulation of early mesoderm/hematopoietic genes, directed differentiation of 
Pcgf6 knockdown-ES cells showed enhanced blast colony formation and increased 
number of hematopoietic colonies (Figure 10, 11). Altogether, results of this study 
suggest that Pcgf6 is involved in maintaining ES cell identity by repressing 
mesodermal/hematopoietic development in undifferentiated ES cells. Therefore, Pcgf6 
may play a role in regulating the initiation of embryonic hematopoiesis.  
 
6.9 Future perspectives 
6.9.1 Overexpression of Pcgf6 in ES cells will provide more insight into the roles 
of Pcgf6 in maintaining ES cell identity 
On certain developmental stages, factors with key regulatory functions act in a dosage-
dependent manner. For example, repression or overexpression of Oct4 leads to a loss of 
ES cell characteristics and induces differentiation towards the trophectodermal or 
meso- and endodermal lineages, respectively (Nichols et al. 1998; Niwa et al. 2000). 
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Analysis on Ring1A mutant mice offered an example for dose-dependent PcG gene 
function. In both Ring1A-/- and Ring1A+/- mice, anterior transformations and 
abnormalities of the axial skeleton were observed indicating the importance of Ring1A 
gene dosage for axial skeleton patterning (del Mar Lorente et al. 2000). Therefore, 
overexpression of Pcgf6 in ES cells or sustained expression of Pcgf6 during ES cell 
differentiation will provide more insight into the roles Pcgf6.  
 
6.9.2 Proteomic analysis will reveal interaction partners of Pcgf6 
In this study, several questions still remain open due to the lack of information about 
Pcgf6 interaction partners. For example, is Pcgf6 involved in any PRC1-independent 
pathways or complexes that play a role in ES cells? We currently are working on ectopic 
expression of Pcgf6 in ES cells via an Avi-tagged Pcgf6-ORF expression vector 
(http://www.genecopoeia.com/tech/avitag-biotinylation-tag/). The Avi-tagged Pcgf6 
protein will be biotinylated in vivo, and subsequently purified in vitro by specific binding 
of streptavidin. Using mass spectrometry, Pcgf6 binding partners will be identified.  
 
6.9.3 The role of Pcgf6 in embryonic spermatogenesis will be addressed via ES 
cell-derived primordial germ cell like cell (PGCLC) differentiation 
Analysis of Pcgf6 knockdown in ES cells revealed regulatory functions of Pcgf6 on 
expression of testis/spermatogenesis genes. In addition, Pcgf6 is highly expressed in 
mouse testis. To functionally address the roles of Pcgf6 during embryonic 
spermatogenesis, we currently are establishing a stable differentiation assay that drives 
ES cells to differentiate into PGCLCs (Hayashi et al. 2011). Using this assay, the Pcgf6 
function for PGCLCT development will be analyzed.  
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7 Material and Methods 
7.1 Material 
7.1.1 Mouse ES cell lines 
Name   
Genetic 
background 
Specific feature  Source 
V6.5   129/Sv X C57BL6  wild type open biosystems 
OG2  CBA X C57BL6 
GFP under 
transgenic Oct4 
promoter control 
kindly provided by Prof. 
Schoeler 
 
7.1.2 Cell culture media and supplements 
Standard ES cell medium 
Ingredient    Concentration Volume Distributor 
DMEM high glucose  fill to 100% 400 ml PAA 
FCS, ES cell tested    15% 75 ml PAA 
Sodium pyruvate    1 mM 5 ml PAA 
Penicillin, Streptomycin  100 U/ml, 0.1 mg/ml  5 ml PAA 
L-Glutamine 2 mM 5 ml PAA 
Non-essential aminoacids   1x  5 ml PAA 
Beta-Mercaptoethanol  0.1 mM 
3.5 µl in 5 ml 
Hepes 
Sigma, PAA 
LIF-conditioned medium  500 µl 
own 
production 
 
ES cell primary differentiation medium (EB medium) 
Ingredient    Concentration Volume Distributor 
IMDM high glucose  fill to 100% 425 ml PAA 
FCS, cell culture tested    10% 50 ml Gibco 
Sodium pyruvate    1 mM 5 ml PAA 
Penicillin, Streptomycin  100 U/ml, 0.1 mg/ml  5 ml PAA 
L-Glutamine 2 mM 5 ml PAA 
Non-essential aminoacids   1x  5 ml PAA 
beta-Mercaptoethanol  0.1 mM 
3.5 µl in 5 ml 
Hepes 
Sigma, PAA 
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Methylcellulose-based medium for blast colony formation 
Ingredient    Concentration Distributor  
IMDM fill to 100% PAA 
Methylcellulose 1% Stem Cell Technologies 
FCS, cell culture tested 10% Gibco 
MTG  4.5 x10-4 M Sigma 
mouse SCF 100ng/ml PeproTech 
mouse VEGF 5 ng/ml PeproTech 
human IL-6 10ng/ml PeproTech 
Holo-transferrin  200µg/ml Sigma 
Ascorbic acid 25 μg/ml Sigma 
L–Glutamine  2 mM PAA 
Penicillin, Streptomycin  1:100 dilution PAA 
Thrombopoietin (TPO) 25ng/ml PeproTech 
 
Methylcellulose-based medium for hematopoietic differentiation 
Ingredient    Concentration Distributor  
IMDM fill to 100% PAA 
Methylcellulose 1% Stem Cell Technologies 
FCS, cell culture tested 10% Gibco 
MTG  4.5 x10^-4 M Sigma 
L–Glutamine  2 mM PAA 
BIT9500 (1% BSA, 10μg/ml 
Insulin, 200μg/ml Transferrin) 
20% Stem Cell Technologies 
mouse SCF 150 ng/ml PeproTech 
human IL-3 30 ng/mL PeproTech 
human IL-6 30 ng/ml PeproTech 
GM-CSF 50 ng/ml PeproTech 
Epo 3 Units/ml 
kindly provided by Prof. 
Sirén 
MEF medium 
Ingredient    Concentration Volume Distributor 
IMDM low glucose  fill to 100% 500 ml PAA 
FCS, cell culture tested    10% 50 ml PAA 
Sodium pyruvate    1 mM 5 ml PAA 
Penicillin, Streptomycin  100 U/ml, 0.1 mg/ml  5 ml PAA 
L-Glutamine 2 mM 5 ml PAA 
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7.1.3 Antibodies 
Primary antibodies 
Target Species Distributor 
H2AK119ub rabbit, monoclonal Cell Signaling 
H2AK119ub mouse, monoclonal Upstate 
H2A rabbit, polyclonal Upstate 
H3 rabbit, polyclonal Abcam 
H3K4me3 rabbit, polyclonal Diagenode 
H3K9me1 rabbit, polyclonal Diagenode 
H3K9me2 rabbit, polyclonal Diagenode 
H3K9me3 rabbit, polyclonal Upstate 
pan acH3 rabbit, polyclonal Upstate 
H4 rabbit, polyclonal Upstate 
pan acH4 rabbit, polyclonal Upstate 
Flk1 rat, monoclonal eBioscience 
CD40 rat, monoclonal eBioscience 
Pcgf6 rabbit, polyclonal abcam 
Pcgf6 goat, polyclonal Santa Cruz 
Pcgf6 mouse, polyclonal Abnova 
ß-Actin rabbit, polyclonal Santa Cruz 
 
Secondary antibodies/reagents 
Target Label Distributor 
mouse HRP Amersham 
rabbit HRP Amersham 
biotin (streptavidin) APC Dianova 
 
7.1.4 Enzymes 
Enzymes Distributor 
BamH1 Fermentas 
Bbs1 Fermentas 
Bfi1 Fermentas 
EcoR1 Fermentas 
Hind3 Fermentas 
Hinf1 Fermentas 
I-Sce1 Fermentas 
Mlu1 Fermentas 
Xho1 Fermentas 
rDNAse1                     Invitrogen 
Super-Taq-DNA polymerase                      Invitrogen 
T4-DNA-Ligase                     Fermentas 
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7.1.5 Primers 
PCR primers for identification of vector integration 
Vector  Target region Sequence 
Size of 
the 
product 
Name of 
the primer 
pair 
pTT5 
flanking the 5 -´
homologe 
sequence of the 
pTT5 vector  
CCTGCAGGGATATCGGTTAC 
(genomic seq.) 
CGCCTAAAGAAGAGGCTGTG 
(pTT5 vector seq.)       
1218 
bp 
P1-L, P1-R 
pINV7 
genomic 
sequence and 
pINV7sequence 
AGGGAGCTGCAGTGGAGTAG 
(genomic seq.) 
TCGTCCTGCAGTTCATTCAG 
(pINV7 vector seq.)         
422 F3-L, F3-R 
 
Gene expression primers 
Target Sequence 
Pcgf1 AGATGGACCCACTACGGAAC 
 GCTGCGTCTCGTGGATCTT 
Pcgf2 CGGACCACACGGATTAAAATCA 
 CGATGCAGGTTTTGCAGAAGG 
Pcgf3 CAGGTAAGCATCTGTCTGGAATG 
 GTAACAACCACGAACTTGAGAGT 
Pcgf4 AATTAGTCCCAGGGCTTTTCAA 
 TCTTCTCCTCATCTGCAACTTCTC 
Pcgf5 GTAAGACCTGTATTGTCCAGCAC 
 TCTCGTAGTCCAGGCACTAATTT 
Pcgf6 GATGCAACCACCATTACAGAGT 
 ACTGCCGGTCCAACCTTATATT 
Pcgf6 GGTTGGACCGGCAGTTACAA 
 CGAAACACTGACTCTAGGACCT 
ß-actin GATATCGCTGCGCTGGTCGTC 
 ACGCAGCTCATTGTAGAAGGTGTGG 
Oct4 CCGTGAAGTTGGAGAAGGTG 
 GAAGCGACAGATGGTGGTCT 
Nanog TCTTCCTGGTCCCCACAGTTT 
 GCAAGAATAGTTCTCGGGATGAA 
Sox2 GCGGAGTGGAAACTTTTGTCC 
 CGGGAAGCGTGTACTTATCCTT 
T CAGCCCACCTACTGGCTCTA 
 GAGCCTCGAAAGAACTGAGC 
HoxA7 TATGTGAACGCGCTTTTTAGCA 
 GGGGGCTGTTGACATTGTATAA 
GSC CAGATGCTGCCCTACATGAAC 
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 TCTGGGTACTTCGTCTCCTGG 
Nodal ACTTTTCTGCTCGACTGGACA 
 CAGATGCTGCCCTACATGAAC 
Flk1 AGGGGAACTGAAGACAGGCTA 
 GATGCTCCAAGGTCAGGAAGT 
Gata6 TTGCTCCGGTAACAGCAGTG 
 GTGGTCGCTTGTGTAGAAGGA 
Sox17  GATGCGGGATACGCCAGTG 
 CCACCACCTCGCCTTTCAC 
Nestin CAGAGAGGCGC GGAACAGAGATT 
 AGACATAGGTGGGATGGGAGTGCT 
Runx1 TTTCGCAGAGCGGTGAAAGA 
 GCACTGTGGATATGAAGGAA 
 
Sequencing primer  
For identification of successful cloning of shRNA oligos into the pINV7 vector, the 
multiple cloning site (MCS) of pINV7 vector was sequenced using the following primer: 
5'-TGTGTTCTGGGAAATCAC-3'.  
 
7.1.6 Plasmid vectors 
RMCE requires the FLP recombinase that is carried by the pINV7 vector. pCAGGS-FLPe 
vector which was always co-transfected with the pINV7 vector provided an extra source 
for FLP recombinase. Because the gene cassettes carried by pCAGGS-FLPe vector were 
no longer needed after the RMCE, no specific drug selection was done for genomic 
integration of this vector. For detailed plasmid maps see the section Attachment. 
Plasmid vector Drug resistance Source 
pTT5 ampicillin, hygromycin All 3 plasmid vectors 
were kindly provided by   
Dr. J. Seibler. 
pINV7 ampicillin, G418 
pCAGGS-FLPe  ampicillin, puromycin 
 
 
7.1.7 shRNA sequences 
shRNA sequence Target region 
shRNA1 (Pcgf6_2) GCACGTAACTACGACTACTTT 1166-1186 (3 U´TR) 
shRNA2 (Pcgf6_3) CCTGAACTTGATATGTCTTTA 780-800 (CDS) 
Scrambled shRNA CCTAAGGTTAAGTCGCCCTCG non 
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7.1.8 Buffers and solutions 
PBS 
137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.76 mM KH2PO4, pH 7.4 
 
FACS-buffer 
PBS, 0.3 % BSA, 0.1% NaN3, pH 7.4 
 
Protein sample buffer 
100 mM Tris HCl pH 6.8, 200 mM DTT, 4% SDS, 0.2% bromophenol blue, 20% glycerol 
 
Trypsin 
0.05% trypsin in PBS, commercially purchased from PAA 
 
Gelatin 
0.1% in PBS 
 
Western blot stripping solution 
100 mM Beta-Mercaptoethanol, 2% SDS, 62.5 mM Tris HCl pH 6.7 
 
Gey's Solution 
20% Stock A: 
NH4Cl 35.0 g, KCl 1.85 g, Na2HPO4-12.H2O 1.5 g, KH2PO4 0.12 g, Glucose 5.0 g,  
Phenol red 50 mg, bring to 1 L 
5% Stock B: 
MgCl2.6-H20 0.42 g, MgSO4-7-H20 0.14 g, CaCl2 0.34 g, bring to 100 ml 
5% Stock C: 
NaHCO3 2.25 g, bring to 100 ml 
70% water 
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7.1.9 Commercail kits and reagents 
Kit / Reagent Distributor 
M-MLV Reverse transcriptase kit  Invitrogen 
Alkaline Phosphatase kit  Sigma 
ABsolute SybrGreen Mix  ThermoFisher 
PeqGold RNAPure  Peq Lab 
RNeasy Mini kit  Qiagen 
AnnexinV-FITC Apoptosis detection kit  BD  
Roche Realtime Ready 96well qRT-PCR Roche Applied Science 
Mouse embryonic stem cell Nucleofection kit  Lonza (Amaxa) 
RNase and DNase free water  Sigma 
Protease inhibitor cocktail  Applichem 
 QIAquick Gel Extraction Kit                                             Qiagen 
 
7.1.10  Plastic consumables, devices and software 
Plastic consumables Distributor 
2 ml cryotubes  PAA 
3.5 cm TC plates  Greiner 
3.5 cm suspension plates  Sarstedt 
6 cm TC plates  PAA 
10 cm TC plates  Greiner 
10 cm petri dish  Greiner 
15 cm petri dish  Sarstedt 
75 cm2 TC flasks, red cap  Sarstedt 
24 well plates TC  Nunc 
24 well plates, suspension  Greiner 
48 well plates TC  Greiner 
15 ml tubes  Greiner 
50 ml tubes  Greiner 
70 µm cell strainer  Greiner 
96 well qRT-PCR plates Roche 
 
 
 
Devices Distributor 
Nucleofector I   Lonza (Amaxa) 
FACS Canto I  BD 
Real time Cycler Rotor Gene 3000  Corbett 
Roche Light Cycler 480 Roche Applied Science 
Cell culture microscope  EVOS AMG 
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Software Distributor 
ImageJ  NIH 
FlowJo  Tree Star, Inc. 
FACS Diva  BD 
Rotor Gene 6  Corbett 
Roche Light Cycler 480 software Roche Applied Science 
Micron  EVOS AMG 
ModFit  Verity software house 
 ApE (A plasmid Editor)   M. Wayne Davis 
 
7.2 Methods 
7.2.1 Cell culture and differentiation 
All cells were cultured under the same condition: at 37°C and 5% CO2 in a humidified 
atmosphere. Cells were frozen in 10% DMSO in FCS.  
 
Establishing and culturing of primary DR4-murine embryonic fibroblasts (DR4 
MEFs)  
DR4 MEFs derived from 13.5 day old DR4 mouse embryos that display resistance to G-
418, hygromycin, puromycin and 6-thioguanin were used for the culture of ES cells 
under drug selection (Tucker et al. 1997). Pregnant females were sacrificed and 
embryos were freed from residual extraembryonic tissue. After removal of heads and 
inner organs, remaining embryonic tissue was incubated in trypsin solution over night 
at 4°C allowing diffusion of the enzyme inside the tissue. The enzymatic activity was 
enhanced by 30 min incubation at 37°C and stopped by adding MEF medium. Further, 
the tissue was disrupted by thorough pipetting, and large tissue particles were then 
allowed to settle down. The supernatant containing single MEF suspension was spun 
down at 200x g and cells were resuspended and plated in MEF medium at a density of 
1/3 embryo per 10 cm tissue culture (TC) plate. One or two days later, adherent 
fibroblasts were designated passage 0.  
Primary DR4-MEFs were either used directly upon isolation or thawed and were used 
for no more than 6 passages. Immortalized DR4-MEFs, in contrast, could be maintained 
in culture for at least 3 months. Longer terms of culturing were not tested. DR4-MEF 
were maintained in TC flasks (T75 or T175) with MEF medium and split twice a week by 
washing them once with PBS, incubating them with minimum volume of trypsin at 37°C 
for maximal 5 min, washing them out with MEF medium and distributing them at equal 
amounts into three new flasks. For mitotic inactivation, proliferating DR4-MEFs were 
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treated with Mitomycin C (Mito C) (10 µg/ml) for 2 to 3 hours, washed at least 2 times 
with PBS, trypsinized and counted. Inactivated DR4-MEFs were plated at a density of 
1x106 cells per 6 cm TC plate. After some hours or the next day MEFs had attached and 
were read as feeder cells for subsequent ES cell culture. 
 
Murine embryonic stem (ES) cell culture 
ES cells were and cultured in standard ES cell medium on inactivated DR4-MEFs in 6 cm 
TC plates. For antibiotic treatment, antibiotics were added to the medium at required 
concentration. Medium was changed daily.  For passaging, ES cells were washed twice 
with 5 ml of PBS and incubated with 1 ml trypsin at 37°C for 5 min. Trypsin reaction was 
stopped by adding 5 ml of ES cell medium and cells were dissociated by pipetting. After 
centrifugation at 90x g, the cell pellet was resuspended in ES cell medium. Desired 
number of ES cells was given to a new culture dish with feeder cells in presence of ES 
cell medium. For inducible knockdown of Pcgf6, 1µg/ml dox in final concentration was 
given into the medium. The medium was changed every day. 
To obtain feeder-free ES cells, cell suspension containing ES cells and MEFs was given to 
a gelatin coated 10 cm TC plate for 45 min. This allows MEFs to strongly attach to the 
bottom of the dish while ES cells only loosely adhere and dead cells as well as cell 
clusters remain in suspension. ES cells are isolated by removing the suspension phase 
and washing off the plate with ES cell medium or 1xPBS.  
 
ES cells colony formation assay 
To analyze the potential of cells to form colonies, defined numbers of feeder-free ES cells 
or differentiated cells were transferred onto a MEF feeder layer in standard ES cell 
medium. After four days the colonies were fixed and the activity of their AP was 
visualized by applying the Alkaline Phosphatase Kit according to manufacturer (see 
Material). Only AP-positive colonies were enumerated by light microscopy. 
 
ES cell differentiation 
To induce differentiation, ES cells were cultured in the absence of LIF and MEFs with 
reduced FCS concentration. In this study, ES cell differentiation was achieved by the 
formation of embryoid bodies (EBs). For inducible knockdown of Pcgf6, 1µg/ml dox in 
final concentration was given into the medium. EBs were generated by clustering 1,000 
ES cells in 30 µl EB medium as “hanging drops” at the lids of 15 cm petri-dish. 1x PBS 
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was added to the petri-dish for humidification. After two days, the formed EBs from one 
15 cm lid (usually 120 EBs) were transferred into 10 cm petri-dishes in 10 ml of fresh 
EB medium and cultured for desired days. For further analyses, EBs were dissociated 
into single cells. For doing this, floating EBs were harvested, allowed to settle down by 
gravity, washing twice in PBS and incubated with trypsin at 37°C for 3 to 10 min.  After 
stopping the trypsin reaction with EB medium, single cell suspension was made by 
gentle pipetting. 
 
Blast colony-forming cell (BL-CFC) assay 
EBs were collected at different days post differentiation, washed in 1xPBS, and treated 
with trypsin at 37ºC for 3 minutes. Dissociated single cells were plated at 5 × 104 cells in 
1ml of BL-CFC methycellulose medium containing a cocktail of growth factors (see 
chapter 7.1). Cells were maintained at 37ºC in a humidified 5% CO2 incubator. After 4-6 
days, developing BL-CFCs were counted. 
 
ES cell derived hematopoietic differentiation  
On day 6, 7 or 9 of ES cell differentiation, EBs were collected, washed in 1xPBS, and 
treated with trypsin at 37ºC for 5-7 minutes. Dissociated single cells were plated at a 
density of 1× 105 cells/ml in hematopoietic methycellulose medium containing a cocktail 
of hematopoietic growth factors (see chapter 7.1). Hematopoietic colonies appeared 
after 6-12 days of culturing at 37°C.    
 
Generation of inducible Pcgf6 shRNA knockdown in ES cells  
OG2 ES cells (carrying an Oct4 promoter-driven GFP transgene) were used for shRNA 
knockdown in this study. 4x 106 ES cells were transfected with 2µg plasmid DNA by 
electroporation using Lonza (Amaxa) mouse ES cell Nucleofection Kit according to 
manufacturer’s guide. Prior to transfection, pTT5 vector was linearized using the 
restriction enzyme I-SceI. Antibiotic selection with hygromycin (200µg/ml final 
concentration) for stable positive clones began 24h after transfection. ES cell medium 
containing hygromycin was changed every day. After 3-5 days of hygromicin treatment, 
ES cell colonies appeared which were picked and clonally expanded. ESC clones carry  
pTT5 gene cassettes in the rosa26 locus were confirmed by PCR using site-specific 
primers. The best suitable ES cell clone was transfected with the pINV7 vector which 
carries the shRNA expression cassettes. The pINV7 vector was co-transfected with the 
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same amount of CAGGS-vector for enhanced flipase activity to achieve more efficient 
recombinase mediated gene cassette exchange. Positive clones carry exchanged shRNA 
expression cassettes were selected by G418 treatment (800µg/ml final concentration). 
ES cell medium containing G418 was changed every day. 
 
7.2.2 FACS staining 
Cell surface marker staining 
For the detection of surface antigens on living cells, fluorochrome or biotin conjugated 
antibodies were used. Single cell suspensions were prepared from ES cells or EBs. 2x105 
cells were washed once and resuspended in FACS buffer, incubated with antibody of 
interest at 4°C for 20 min. After 2 washing steps with FACS buffer, cells stained with 
were fluorochrome conjugated antibodies were resuspended in 100µl FACS buffer and 
ready for analysis. Cells stained by biotin conjugated antibodies were incubated  with 
Streptavidin-APC (1µl/1ml) in 100 µl FACS buffer at 4°C for 20 min, washed twice with 
FACS buffer and resuspended in 100µl FACS buffer for FACS analysis. Approximately 
10,000 events were gated for each sample. The working dilutions of the antibodies are 
listed below: 
Flk1: 1μl/50μl 
CD40: 0.5μl/50μl 
 
Cell cycle analysis by propidium iodide (PI) staining 
To indentify the phases of the cell cycle, DNA content in cells was measured by staining 
with the DNA binding dye propidium iodide. The measurement occurred by using FACS. 
Data were analyzed with Modfit software. Approximately 2x105 cells were fixed in ice-
cold 70% ethanol at -20°C for at least 30 min, or stored at -20°C for up to one week. Cells 
were washed twice in 1xPBS, resuspended in 200µl 1xPBS and incubated with 100 
µg/ml RNase and 50 µg/ml PI at 37°C for 30 min. Cells were immediately analyzed.  
 
Apoptosis analysis by combined AnnexinV and 7AAD staining 
Approx. 2x 105 freshly harvested cells were washed once in 1x binding buffer and 
incubated with 5µl AnnexinV-PE and 2.5µl 7AAD in 100 µl 1x binding buffer for 15min at 
37°C. Immediately cells were analyzed. 
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Cell proliferation analysis by bromodeoxyuridine (BrdU) incorporation  
ES cells on inactivated MEFs were incubated with 10 μM BrdU in ES cell medium for 
various times (0.5–6 h). ES cells were harvested without being separated from MEFs to 
avoid losing apoptotic cells. Cell were washed once with PBS and fixed in 70% ethanol 
overnight. 2 N HCl/0.5% Triton X-100 solution was used to denature DNA then 
neutralized with 0.1 M Na2B4O7·10 H2O, pH 8.5 solution. During these procedures, EGFP 
proteins in OG2 ES cells were denatured and no longer detectable. Cells were incubated 
with FITC-conjugated anti-BrdU antibody for 60min at room temperature. After 2 
washing steps in FACS buffer, the cells were ready for analysis.  
 
7.2.3 Isolation of mouse tissues 
BM isolation 
Female C57BL6 mice at an age of 8 to 12 weeks were sacrificed, femur and tibia bones 
were isolated and the BM was flushed out with 0.3% BSA in PBS by using needle and 
syringe. Single cell suspension was obtained by thorough pipetting and the pass though 
a 70 µm cell strainer. Erythrocytes were depleted by incubation in hypotonic Gey's 
solution for 5 min on ice and the BM cells were subsequently collected in a phase of FCS 
by centrifugation. 
 
Testis isolation 
Male C57BL6 mice at an age of 3 days to 12 weeks were sacrificed. Isolated testes were 
immediately given into liquid nitrogen to prevent RNA degradation.   
 
7.2.4 Molecular biology 
Bacterial transformation 
Calcium sulfate competent DH5α-Escherichia coli (E. coli) were thawed at room 
temperature and immediately transferred onto ice. 50µl of the competent DH5α were 
mixed with 100pg – 100ng plasmid DNA and incubated on ice for 30 minutes. After heat 
shock at 42°C in water bath for 30 seconds, the bacteria were transferred into ice bath 
for 2 min before 500µl of LB medium was added. The bacteria suspension was 
vigorously shaken at 37°C for 1 hour.  
For selecting the positive clones the transformed cells were plated onto LB agar plates 
containing antibiotics and incubated at 37°C over night. One exception here was the 
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culturing of E. coli carrying pTT5 vector that required a lower temperature of 30°C to 
avoid mutations.  
 
Isolation of plasmid DNA from E. coli 
Plasmid DNA was amplified in 150 ml E. coli culture (LB medium) under vigorous 
shaking overnight at 37°C. Amplification of pTT5 vector in E. coli required shaking at 
30°C for 24 hours. Plasmid isolation from E. coli was done with MaxPrepKit from 
Qiagene according to the manufacturer s´ guide. Plasmid DNA were solved in tris-buffer 
(PH 7.8) and stored at -20°C.  One exception here was the culturing of E. coli carrying 
pTT5 vector that required shaking at 30°C for 24 hours to avoid mutations.  
 
Linearization and purification of pTT5 vector 
40µg of pTT5 vector was linearized by 40 units of I-Sce1 in 1x Tango-buffer at 37°C over 
night. Digested plasmid DNA was separated by agarose gel electrophoresis, and 
subsequently isolated from the gel by using Plasmid Gel Purification Kit of Qiagen 
according to the manufacturer s´ guide.  
 
Annealing of shRNA oligos 
shRNAs were ordered as forward (F) and reverse (R) DNA oligos. Annealing of the 
shRNA oligos was performed as following: 10 µM of each F and R oligos were mixed with 
in 1X ligation buffer (Fermentas) and H2O in a total volume of 25 µl. The mixture was put 
into a PCR thermocycler, and sequentially incubated at 95°C for 10 min, at 75°C for 10 
min and ramp cooled down to 25°C. Annealed oligos were never heated again and stayed 
always on ice or frozen. 
 
Cloning of shRNA oligos into pINV7 vector 
Before ligation, pINV7 vector was digested with Bbs1 and Mlu1 and purified from 
agarose gel using QIAquick Gel Extraction Kit (Qiagen). 50ng of digested and purified 
pINV7 plasmid DNA was mixed with 0.05 pmol of annealed shRNA oligos, 1µl of 10x 
ligase buffer, 1µl of T4 ligase (Fermentas) and brought to a final volume of 10µl with 
nuclease-free water. The ligation took place at 22°C for 1 hour. T4 ligase was inactivated 
by incubation in 65°C water bath for 10 min, before the pINV7-shRNA vector was 
transformed into E. coli.  
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DNA sequencing 
The successful ligation of pINV7 vector and shRNA oligos was confirmed by DNA 
sequencing. 1µg DNA was mixed with 10pM sequencing primer and was send to the 
company SeqLab. Sequencing data were analyzed using the software ApE. 
 
RNA isolation 
Total RNA of cells was purified by using peqGOLD RNA Pure Kit, an optimized guanidine 
isothiocyanate/phenol reagent for RNA extraction, or by the Qiagen spin column RNeasy 
Mini Kit. RNA isolation was performed as recommended by the manufacturer. The 
concentration and purity of the RNA was determined using photospectrometry. 
 
cDNA synthesis 
Purified RNA was reverse transcribed by the M-MLV reverse transcriptase. DNase was 
used to remove the remaining genomic DNA. Briefly, 1 µg of total RNA were treated with 
DNase at 37°C for 30 min. The reaction was stopped by adding 7% v/v 25 mM EDTA and 
incubating at 65°C for 10 min. Oligo dT primers (5' TTT TTT TTT TTT TTT T 3') were 
allowed to anneal to poly-A RNA 65°C for 5 min, followed by rapid chill down on ice. 
Subsequently, RNA was incubated with 5 mM dNTPs, reverse transcriptase and first-
strand buffer at 37°C for 1 hour. cDNA was further diluted with RNase and DNase free 
water before qRT-PCR. 
 
Quantitative realtime PCR 
qRT-PCRs were performed using Syber-Green Mix or taq-man master mix in Roche Light 
Cycler 480. For general gene expression analyses, 1 µl cDNA (~50ng) was mixed with 10 
µl 2x Sybr-Green Mix, 8.5 µl water and each 0.25 µl of 100 pM primers. Analyses were 
referred to beta-actin and Hprt by the delta-delta Ct calculation. All reactions were 
carried out as duplicates with the following PCR program: 95°C for 15 min, 40x (95°C for 
10 s, 60°C for 20 s, 72°C for 30 s, 80°C for 20 s), 50°C for 1 min, 67°C to 95°C with 0.5°C 
temperature increase per 5 s. Ct values were determined by Roche Light Cycler 
software. 
The Roche Realtime Ready 96-well PCR array was used with cDNA which was 
synthesized from Qiagen purified RNA. After dilution (1:5) each 1 µl cDNA together with 
water and Light Cycler 480 Probes Master Mix was placed per well, as recommended by 
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the manufacturer. Roche Light Cycler software determined Cp values automatically and 
results were normalized to ß-Actin, Hprt and Rp113a. 
 
Global gene expression analysis (Microarray) 
RNA was isolated using RNeasy Mini Kit (Qiagen). The RNA quality was checked by 
agarose gel electrophoresis and the UV spectroscopy (A260/280 ratio). Microarray and 
determination of gene expression levels were performed by Prof. M. Zenke, Qiong Lin 
and colleagues. Briefly, sample preparation was performed according to the Expression 
Analysis TechnicalManual (Affymetrix). Gene Chip One-cycle Target Labeling Kit 
(Affymetrix) and 1 mg total RNA were used. Biotin-labeled cRNA was hybridized on 
Affymetrix Mouse Genome 430 2.0 GeneChip arrays. Arrays were stained, washed, and 
scanned according to the manufacturer’s protocols. Gene expression levels were 
determined by GCRMA algorithm in R/Bioconductor. Hierarchical clustering was 
performed using Pearson correlation coefficient and the average linkage method and 
represented by dendrogram and heat-map (Data not shown). Differential expression 
between 2 conditions was analyzed using Student’s t-test. The transcripts with fold 
change >2 and P-values < 0.05 were considered as being differentially expressed. Raw P-
values were adjusted by Benjamini and Hochberg’s method. Subsequent data-mining 
was done by me.  
 
Western blot 
Protein samples were prepared from 1 x 106 cells which were lysed in 100 µl protein 
lysis buffer and sheared by passing through a 21 gauge needle for several times. Samples 
were heated up to 95°C for 5 min and proteins were separated by SDS-PAGE in 12% SDS 
gels. Proteins were next blotted onto nitrocellulose membranes followed by blocking of 
unspecific binding sites in 5% milk in PBS with 0.1% Tween20 at room temperature for 
30 min. Subsequently, membranes were incubated with primary antibodies in 1x PBS 
containing1% milk and 0.1% Tween20 at 4°C over night. After three washes secondary 
HRP-coupled antibodies were incubated with the membranes in 1x PBS containing 0.1% 
Tween20 at room temperature for 2 h. Proteins were detected by ECL addition and 
chemiluminescence measurement, either by X-ray film or by BioRad Imaging system. 
Membranes were stripped from antibodies incubation with stripping solution at 56°C 
for 30 min. 
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